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Zusammenfassung 
 
Es gibt viele Schritte und Mechanismen die die RNA während und nach der 
Transkription prozessieren und modifizieren. Ein Beispiel 
posttranskriptioneller Modifikation ist RNA-editing, welches Deletion, 
Insertion oder chemische Umwandlung von Nukleotiden umfasst. Adenosin zu 
Inosin RNA editing wird durch Enzyme katalysiert, die ADARs ( adenosine 
deaminase that act on RNA) genannt werden welche in den meisten Metazoan 
gefunden werden konnten. Als Folge der Veränderung der RNA Sequenz, 
können die Eigenschaften der RNA Moleküle und der translatierten Proteine 
modifiziert werden. ADARs agieren an partiell oder perfekt doppelsträngigen 
RNAs und sind an einem breiten Spektrum von zellulärer Funktionen beteiligt. 
Menschliches ADAR1 hat die Fähigkeit zwischen Nukleus und Cytoplasma zu 
pendeln und besitzt zwei Promotoren, welche zu zwei Versionen des Proteins 
führen. Das längere, Interferon induzierte, enthält einen Nuklear Export 
Signal (NES) und ist im Nukleus sowie im Cytoplasma lokalisiert. Das kürzere 
hat einen gekürzten Aminoterminus, ist konstitutiv exprimiert und vorwiegend 
nukleär. Die dritte doppelstrang RNA bindende Domäne von ADAR1 wird von 
einem untypischen Nuklear Lokalisierung Signal (NLS) überlagert. 
Ziel dieser Arbeit war es, die dritte doppelstrang RNA bindende Domäne 
(dsRBD3) von menschlichen ADAR1 zu charakterisieren, indem ihre 
dreidimensionale Struktur bestimmt werden sollte. Daher wurden 
unterschiedliche Konstrukte diese Proteins gemacht, welche sich in der Länge 
ihrer N- oder C- Termini unterschieden, um hochkonzentriertes, Protein für 
Kernspinresonanzspektroskopie (NMR), zu reinigen. Zusätzlich wurden 
verschiedene Puffer, Temperaturen, pH- Werte, Inkubations- und 
Induktionszeiten getestet um die besten Konditionen für dieses Protein zu 
finden. 
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Abstract 
 
There are many steps and mechanisms that process and modify RNA during 
and after transcription. One example of a post-transcriptional processing 
event is RNA-editing which includes deletion, insertion or chemical 
conversion of nucleotides. Adenosine to inosine RNA editing is catalyzed by 
enzymes named adenosine deaminases that act on RNA (ADARs), which are 
found in most metazoa. As a consequence of the alteration of the RNA 
sequence, the properties of the RNA molecules and of the translated 
proteins can be modified. ADARs act on partially or perfectly double 
stranded RNA and are involved in a wide range of cellular functions. 
The human adenosine deaminase that acts on RNA 1 (ADAR1) has the 
ability to shuttle between the nucleus and cytoplasm and possesses two 
promoters which lead to the expression of two versions of the protein. The 
longer one, interferon inducible, contains a nuclear export signal (NES) and 
in contrast to the shorter one is located in the nucleus as well as in the 
cytoplasm. The shorter one, has a truncated amino-terminus, is 
constitutively expressed and predominantly nuclear. The third double 
stranded RNA binding domain of ADAR1 is overlapped by an atypical 
nuclear localization signal (NLS). 
The objective of this work was to characterize the third double stranded 
RNA binding domain (dsRBD3) of the human ADAR1, by determining its 
three dimensional structure. For this purpose different constructs of this 
protein which differ from each other in the length of their N- or C-termini, 
were made to achieve a high concentrated, non aggregated protein for 
nuclear magnetic resonance spectroscopy (NMR). Additionally different 
buffers, temperatures, pH values, incubation and induction times, were 
tested to find the best conditions under which this protein is suitable for 
NMR analysis. 
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Introduction 
 
 RNA editing 
RNA editing is a post-transcriptional processing event, which is widespread 
in eukaryotes. It can increase the genetic variation because functionally 
distinct proteins can be produced from a single gene. The molecular 
mechanisms by which editing reactions operate are different and range from 
nucleotide insertion or deletion to base modification. In addition to codon 
changes, this type of modification has been shown to generate both 
introduction and removal of stop codons as well as change of splice sites 
(Maas and Rich 2000).  
 
Types of RNA editing 
The phenomenon of RNA editing was first discovered more than 20 years 
ago in kinetoplastid protozoa (Benne, Vandenburg et al. 1986). Here, in the 
mitochondrial mRNA, many uridine nucleotides are inserted or deleted. 
These events can produce open reading frames, create translation initiation 
cordons and correct frame shifts (Feagin, Abraham et al. 1988; Maslov and 
Simpson 1992; Alfonzo, Thiemann et al. 1997). In protozoa, guide RNAs 
define the uridine insertion/deletion sites, where editing must occur. The 
sequence of these guide RNA represent complementary versions of the 
mature mRNA within the edited region. A hybrid formed between the gRNA 
and preedited RNA is substrate for multiple cycles of cleavage, addition or 
deletion of uridylates and religation (Blum, Bakalara et al. 1990).  
Another type of RNA editing is base conversion/substitution editing which 
includes cytidine to uracil and adenosine to inosine deamination. 
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Cytidine-to-uridine editing is performed in RNA by many cytidine 
deaminases. The reaction that occurs thereby is a hydrolytic deamination at 
C4 of cytidine. This particular editing event was found in vertebrate mRNA  
which codes for apolipoprotein B (apoB), a structural component of plasma 
lipoproteins and a significant risk factor for the development of 
atherosclerosis (Chan 1992). The editing of apo-B mRNA involves the site 
specific deamination of C666 to U, which converts codon 2153 from a 
glutamine codon CAA, to a premature stop codon UAA (Chen, Habib et al. 
1987). In consequence of that , both a truncated apoB48 and the full length 
variant (apoB100) are produced by a single gene, which have distinct 
functions in lipoprotein metabolism and atherosclerosis susceptibility 
(Innerarity, Boren et al. 1996). In most mammals apoB mRNA editing is 
restricted to the intestine but it may also be found in the livers of some 
species, including rodents and hepatic expression of apoB mRNA editing 
influences lipoprotein concentration in plasma (Greeve, Altkemper et al. 
1993). 
 ApoB-mRNA is edited by APOBEC1, a member of CDARs family (cytidine 
deaminases that act on RNA). APOBEC1 can not edit selectively by itself , 
only by forming a complex with a factor named APOBEC1 complementation 
factor ACF, which has been shown to bind to apoB mRNA in vivo and in 
vitro (Mehta, Kinter et al. 2000). 
 Cytidine residues are deaminated by members of APOBEC family not only 
in RNA but also in single stranded DNA. Two members of this family, 
APOBEC3F and APOBEC3G, affect the effinciency of retroviruses by 
deaminating cytosines in nascent retroviral cDNA of the human 
immunodeficiency virus (HIV) which in turn, encodes Vif, a small protein 
that mediates APOBEC inactivation (Harris and Liddament 2004). Another 
example of members of APOBEC family is Activation Induced Deaminase ( 
AID), which plays a significant role in variegation and expression of 
immunoglobulins (Neuberger, Harris et al. 2003). 
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The reverse editing event to C-to-U has also been detected. Uridine to 
cytidine has been observed mostly in plants but also in RNA in amphibians 
and mammals (Malek, Lattig et al. 1996). 
 
                        
Figure 1: Cytidine and adenosine deamination in RNA 
(Gerber and Keller, 2001). During editing cytosine and adenine are converted to 
uridine and inosine respectively by a hydrolytic deamination of the bases. 
 
Additionally to the above-mentioned editing types, adenosine to inosine is 
the most widespread editing event in mammals. This phenomenon 
contributes in transcriptome diversification, it can have an impact on RNA -
structure, -localisation, -stability, splicing, and translation. Changes in gene 
expression are a consequence of the fact that during translation inosine is 
recognized as a guanosine, thereby causing changes in amino acids and 
often in protein function. 
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 Adenosine deaminases that act on RNA (ADARs) 
Adenosine deaminases that act on RNA (ADARs) can accomplish the 
reaction of hydrolytic deamination of adenosine to inosine. This enzymes 
were first indentified in Xenopus eggs and it was thought that there is a 
mysterious dsRNA-unwinding activity (Bass and Weintraub 1987), but 
further work showed that there occurs an adenosine to inosine deamination.  
It has been shown that ADARs are present in all metazoans and were 
successfully isolated from mammals (Kim, Wang et al. 1994), frogs (Hough 
and Bass 1997), fish (Slavov, Crnogorac-Jurcevic et al. 2000), birds (Herbert, 
Lowenhaupt et al. 1995), flies (Palladino, Keegan et al. 2000) and worms 
(Tonkin, Saccomanno et al. 2002). 
All ADARs have some common features; they contain at the C-terminal end 
a highly conserved catalytic domain and in the region of their N-terminus 
variable numbers of double stranded RNA binding domains. ADARs act on 
completely base-paired dsRNA structures, which are recognized by the 
double stranded RNA binding domains (dsRBDs), and they do not need 
additional cofactors to be active. 
In mammals three ADAR enzymes are known.  
ADAR 1 is an omnipresent protein whose expression is regulated. The 
presence of two promoters leads to expression of two isoforms, a long and a 
short protein. The longer one, 150 kDa ADAR1i, is mainly cytoplasmic and 
is expressed from an interferon inducible promoter (Liu, George et al. 1997). 
In contrast to other ADARs, ADAR1i has a long amino-terminal extension 
that encloses two Z- DNA binding domains (Herbert, Alfken et al. 1997), 
which may contribute to the localization of the enzyme near to DNA that is 
transcribing ADAR substrates (Herbert and Rich 2001). ADAR1c, is 110kDa 
in size and its expression is conducted by the second promoter, the 
constitutive one. This form of ADAR1 lacks the first 295 amino acids of the 
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longer form because of alternative splicing (Patterson and Samuel 1995). 
Consequently it lacks the Zα subdomain which contains a nuclear export 
signal (NES) Because of this absence and the presence of a nuclear 
localization sequence (NLS), which is overlapped by the third RNA binding 
domain (dsRBD3) of the protein (Eckmann, Neunteufl et al. 2001), ADAR1c 
accumulates in the nucleus. However, it is believed that both isoforms can 
edit pre-mRNA site-specifically, independent of their localization. Other 
features of ADAR1 are the catalytic domain in the C-terminus and three 
double stranded RNA binding domains; in human the third of these, as 
mentioned above, overlaps with a nuclear localization signal in the amino 
terminal region, whose activity does not depend on RNA binding (Eckmann, 
Neunteufl et al. 2001). ADAR1i has the ability to shuttle between nucleus 
and the cytoplasm due to the presence of both, nuclear localization and 
export signals. Additionally, ADAR1i- N-terminus harbors an arginine- 
glycine (RG) rich domain, whose function is not known (O'Connell, Krause 
et al. 1995). 
Furthermore, even though ADAR1c lacks a classical nuclear export signal 
(NES), it is also able to shuttle between the nucleus and cytoplasm 
(Strehblow, Hallegger et al. 2002). 
ADAR2 is mainly expressed in the nervous tissue. It is structurally similar 
to ADAR1, nevertheless it has only two double stranded binding domains, 
and lacks a Z-domain in the N terminal region. There are two isoforms of 
human ADAR2, the longer one (ADAR2L) possesses, in contrast to the 
shorter one (ADAR2S), an Alu-sequence inserted into the deaminase domain 
(Gerber, O'Connell et al. 1997). An aminoterminal nuclear localization 
signal (NLS) is also present in ADAR2, which gives this protein the ability 
to accumulate in the nucleus. Within the nucleolus ADAR1 and ADAR2 co-
localize in a novel compartment and they are in constant flux in and out of 
the nucleolus (Desterro, Keegan et al. 2003). 
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ADAR3 shows a high (72%) homology to ADAR2. Beside the catalytic 
domain and the two double stranded RNA binding domains, ADAR3 
includes also an arginine/lysine rich domain at its N terminal region, which 
has the ability to bind single stranded RNA. The presence of this single 
stranded RNA binding domain and its expression only in specific tissues 
make it different from ADAR1 (Chen, Cho et al. 2000). Another difference is 
that ADAR3 shows no editing activity on known substrates in vivo as well 
as on synthetic dsRNA. 
ADATs.   
Through searches in yeast and Drosophila with ADAR-type deaminase 
motifs, a group of enzymes adenosine deaminases that act on tRNA 
(ADATs), were identified. These enzymes deaminate adenosine to inosine in 
tRNA at position A37, next to the anticodon or in the wobble position A34. 
The similar deaminase domain suggests an evolutionary relationship to 
ADARs (Gerber, Grosjean et al. 1998). 
 
Figure 2: Schematic diagram of human ADARs 
(Keegan, Gallo et al. 2001). The enzymatic activity of all ADARs is accomplished 
through the deaminase domain in the C terminus. An important role in RNA 
recognition plays the double stranded RNA binding domains in the N terminal region. 
In this region in ADAR1 are additionally present two Z DNA binding domains and a RG-
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enriched domain. A nuclear localization sequence is also contained in all proteins 
(Keegan, Gallo et al. 2001). 
Mechanism and types of A to I editing in vivo 
In vivo, there are two types of A to I editing :  
Hyper-editing of multiple adenosines, has been almost found within 
untranslated regions, longer and completely duplexed structures whose 
functional consequences are still unclear (Athanasiadis, Rich et al. 2004; 
Levanon, Eisenberg et al. 2004) 
The other type is the site selective editing of substrates. Here only a few 
adenosines within an imperfect RNA fold-back structure are edited. It is 
supposed that internal mismatches and bulges within an RNA duplex are 
important for ADAR selectivity. However, it is still not fully understood 
which properties make an RNA suitable for site selective editing (Kallman, 
Sahlin et al. 2003; Stephens, Haudenschild et al. 2004). 
Binding and catalysis are independent events therefore it could be that 
ADAR enzymes bind to various transcripts nonproductively (Kallman, 
Sahlin et al. 2003). It was thought that ADARs binds to editing sites as 
monomer but some works have suggested that catalytic ADAR is a dimer, 
and this dimerization is required for RNA editing activity of ADARs (Cho, 
Yang et al. 2003; Gallo, Keegan et al. 2003). In order that catalysis occurs 
two monomers must bind, therefore dimerization is probably what 
contributes in specificity of editing. Additionally, for ADAR editing the 
double stranded RNA structure and an editing complementary sequence is 
required in all known substrates (Gerber and Keller 2001). It was shown 
that editing sites are only coupled within specific distances from each other 
and the coupled sites of editing are positioned on the same side of a helix, 
indicating that the three dimensional structure is key in ADAR enzyme 
substrate recognition (Enstero, Daniel et al. 2009). 
16 
 
Substrates of adenosine deaminases that act on RNA 
Editing in non-coding regions 
 
In non-coding regions a great number of human adenosine to inosine RNA 
editing sites has been identified. These regions consist of inversely oriented 
repetitive elements, mostly Alu elements and some LINE. It is predicted 
that more than 85% of pre-mRNA may be edited, with the vast majority 
being targeted in introns and UTRs (Athanasiadis, Rich et al. 2004; 
Levanon, Eisenberg et al. 2004). Alu elements are short interspersed 
elements (SINEs). They are repeat sequences of about 300 base pairs in 
length, are abundantly found in primates  and show a dimeric structure 
formed by fusion of two monomers derived from the 7SL RNA gene (Kriegs, 
Churakov et al. 2007). In different tissues there are various editing levels of 
Alu- containing mRNA, which correlates with the homology between 
inverted repeats, frequency of the SINEs and their distance (Athanasiadis, 
Rich et al. 2004; Levanon, Eisenberg et al. 2004). 
It was proposed that editing in untranslated regions have a strong impact 
on the transcriptome and proteome through regulation of splicing, RNA 
structure, RNA stability and RNA retention (Chen, DeCerbo et al. 2008).  
Additionally to repetitive elements, editing can also modify microRNA 
precursors and microRNA sequences. Editing can change the seed sequence 
in microRNAs, a small region near the 5`end of the miRNA which is 
important in defining target specificity, and targeting sequences in mRNAs, 
leading to inhibition or alteration of processing (Kawahara, Zinshteyn et al. 
2007; Kawahara, Zinshteyn et al. 2007; Kawahara, Megraw et al. 2008). 
A new function of editing in the control of miRNA biogenesis is the 
suppression of processing of pri-miR-142 by Drosha, the precursor of miRNA 
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142. The edited pri-miR-142 was suggested to be degraded by Tudor-SN, a 
component of RISC and also a ribonuclease specific to inosine-containing 
dsRNAs (Yang, Chendrimada et al. 2006). Additionally, it has also been 
shown that as a result of RNA editing of pri-miR-151, its cleavage by Dicer 
and accumulation of the edited pre-miR-151 RNAs is completely blocked 
(Kawahara, Zinshteyn et al. 2007). 
 
Editing in coding regions 
 
Mammalian glutamate receptor.  
The glutamate receptors are ligand-gated ion channels expressed mainly in 
the central nervous system that mediate the vast majority of excitatory 
neurotransmission in the brain. There are three subgroups of the glutamate 
receptors which show differences in agonist activation and pharmacological 
characterization : AMPA, NMDA and kainate receptors (Dingledine, Borges 
et al. 1999). 
ADARs can edit five of the gluR subunits: gluR-B, -C, -D, -5, and -6. In gluR-
B editing of two exonic sites lead to functional consequences: Q/R site which 
is located in exon 11 and R/G site located in exon 13. Editing at the Q/R site 
changes a glutamine codon to an arginine codon leading to a lower Ca+ 
permeability of the channel (Hume, Dingledine et al. 1991; Burnashev, 
Monyer et al. 1992). Additionally editing at this site is necessary for an 
accurate tetramer assembly of AMPA receptor (Greger, Khatri et al. 2003). 
Editing at the R/G site allows faster recovery of the receptor from 
desensitization due to a convertion of an arginine codon to a glycine codon 
(Lomeli, Mosbacher et al. 1994). The Q/R site is edited only by ADAR2 
whereas R/G site can be edited by ADAR1 and ADAR2 (Higuchi, Maas et al. 
2000).  
 An increased Ca+ permeability because of underediting of glutamate 
receptors lead to severe epileptic seizures and death within two weeks of age 
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(Brusa, Zimmermann et al. 1995). Furthermore after inactivation of the 
editing enzyme ADAR2, the same phenotype is observed (Higuchi, Maas et 
al. 2000).  
The R/G site shows different editing levels during development and the 
convertion of arginine to glycine at this position is not essential (Lomeli, 
Mosbacher et al. 1994). It has been shown that editing at R/G site facilitates 
alternative splicing events occurring downstream of this site, due to 
reducing splicing efficiency of the adjacent intron.  
Decreased editing at Q/R site has also been shown to lead to accumulation of 
incompletely spliced gluR-B transcripts and as a result of that they still 
contain the intron in which the ECS (editing site complementary sequence) 
for this site is located (Higuchi, Maas et al. 2000; Schoft, Schopoff et al. 
2007). 
 
Mammalian serotonin receptor 
 
Serotonin (5-HT) is a neurotransmitter that is involved in the regulation of 
cognition, mood, aggression, appetite and sexual behavior.   
5HT2C serotonin receptors are G-protein coupled receptors, which transmit 
extracellular signals through this interaction. In the mRNA of the 2C 
subtype of serotonin receptor, five sites have been shown to be edited from 
ADAR enzymes (termed as site A to E), leading to five codon exchanges 
(Burns, Chu et al. 1997). ADAR1 edits the A and B sites while the C, D and 
E sites are edited by ADAR2 (Higuchi, Maas et al. 2000; Wang, Khillan et 
al. 2000).  
As RNA editing can change the serotonin response, and serotonin has 
important functions in the central nervous system, some psychiatric 
disorders such as depression and anxiety are thought to be implicated with 
altered RNA-editing patterns (Niswender, Herrick-Davis et al. 2001).  
Additionally, it was suggested that RNA editing has the ability to regulate 
serotonergic signal transduction and that this modification may be 
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important in regulating functions that are interceded by other members of 
the G-protein coupled receptor superfamily (Burns, Chu et al. 1997; 
Schmauss 2005).  
 
 RNA editing in invertebrates 
 
In Drosophila melanogaster only one ADAR gene is known, which is most 
homologous to mammalian ADAR2 and is expressed in the developing 
nervous system (Palladino, Keegan et al. 2000). The best characterized 
dADAR targets are transcripts that encode ion channel subunits as the 
pore-forming α1 subunit of a voltage gated calcium channel (Kawasaki, 
Collins et al. 2002), α1 subunit of a voltage gated sodium channel 
(Hanrahan, Palladino et al. 2000) and glutamate gated chloride channel 
(Semenov and Pak 1999). Drosophila ADAR edits also its own mRNA 
changing a conserved residue in the catalytic domain, a process which is 
developmentally regulated (Palladino, Keegan et al. 2000). 
Drosophila ADAR mutants lack site selective editing of all known pre-
mRNA targets and also nonspecific adenosine deamination activity leading 
to adult behavioral defects which increase in severity with age and are 
associated with neurodegeneration (Palladino, Keegan et al. 2000) 
Caenorhabditis elegans possesses two ADAR genes adr-1 and adr-2; adr-1 is 
expressed in the most cells of the nervous system and in the developing 
vulva. Both of these genes have different roles in RNA editing and are 
essential for normal function of the nervous system (Tonkin, Saccomanno et 
al. 2002). 
 
Viral RNA editing  
 
 The interferon system is the first line of defense against viral infection in 
mammals and because of that it was naturally to examine the role of 
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ADAR1 in viral replication because the long form of ADAR1 is interferon 
inducible (reviewed in (Sen 2001)). 
Modification by an ADAR enzyme can lead to sequence changes also in viral 
transcripts (Cattaneo 1994). These sequence changes are frequently 
nonselective or of the hypermutation type of deamination that occurs in 
substrates that are completely double stranded. In some cases the viral 
transcripts form intramolecular hairpins (O'Hara, Horodyski et al. 1984; 
Hajjar and Linial 1995) or interact with an antisense molecule (Kumar and 
Carmichael 1997), but in some other cases it not clear how dsRNA forms. 
Formation of aberrant double stranded structures between the plus and 
minus strands or the minus strands and an mRNA, has been suggested for 
RNA viruses that replicate through an RNA intermediate (Bass, Weintraub 
et al. 1989).  
One example of the high probability that ADAR1 functions in host defense 
mechanisms against viral infection and inflammation is the fact that editing 
of hepatitis C virus RNA genome inhibits its replication. This can explain 
successful HCV replicon clearance by IFN-α in vitro and my present a 
promising new therapeutic strategy for HCV as well as other viral infections 
(Taylor, Puig et al. 2005). Another example is the increase of the inosine-
containing mRNAs in T lymphocytes and macrophages stimulated with a 
variety of inflammatory mediators, including tumor necrosis factor-α (Yang, 
Luo et al. 2003). Furthermore, the interaction between ADAR1 and nuclear 
factor 90 family proteins affects the NF90-mediated gene regulation (Nie, 
Ding et al. 2005). NF90, also known as interleukin enhancer-binding factor 
3 (ILF3), is a regulator that stimulates the activation of the cellular 
antiviral expression cascade and activates interferon-β (Nie, Ding et al. 
2005). ADAR1-NF90 interaction suppresses the interferon activation 
pathway. This suppression is important for protecting hematopoietic 
progenitor cells from apoptosis (Hartner, Walkley et al. 2009). Other 
evidence that supports the function of ADAR1 in DNA-mediated immune 
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response is its inhibitory effects on interferon-β induction to the cellular 
response to DNA treatment (Wang, Choi et al. 2008). 
 
Biological relevance of editing in Human 
Dyschromatosis symmetrica hereditaria (DSH), also known as symmetrical 
dyschromatosis of the extremities, is a pigmenting genodermatosis 
concentrated on the dorsal extremities with an autosomal dominant 
inheritance. The locus for this disease was mapped on chromosome 1q21.3 to 
the ADAR gene. There are 32 ADAR1 mutations identified in DSH patients. 
H216fs is a frame shift mutation located upstream of the methionine codon 
296, which is the initiation codon for translation of the p110 form of ADAR1 
(Patterson and Samuel 1995). Besides the knowledge that the dosage of the 
functional p150 protein is a dominant denominator of DSH, it has also been 
shown that this protein is involved in apoptotic pathways (Wang, Miyakoda 
et al. 2004), and seems to regulate cellular RNAi efficacy by sequestering 
siRNA (Yang, Wang et al. 2005). 
It was suggested that RNA editing might have an effect also in Amyotrophic 
lateral sclerosis (ALS). ALS is a progressive neurodegenerative disease 
causing muscle weakness, spasticity, muscle atrophy and at a late time 
paralysis and respiratory failure. In ALS there is an excessive Ca2+ influx 
through glutamate receptors which contribute to neuronal death (Spreux-
Varoquaux, Bensimon et al. 2002). It was found that editing of the GluR-2 
Q/R position was decreased in most samples of diseased neurons whereas all 
control cells showed 100% editing, which indicates that abnormal editing 
may contribute to neuronal death specifically to sporadic ALS (Kawahara, 
Ito et al. 2004; Kawahara and Kwak 2005). 
Other diseases in which RNA editing might play a role are epilepsy, 
depression and schizophrenia. It was shown that epileptic phenotypes are 
most profound in GluR-2 editing deficient mice and the severity of seizures 
activity correlates directly with the degree of impairment in the editing of 
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Q/R site (Feldmeyer, Kask et al. 1999). Furthermore there are multiple 
groups that reported an increased RNA editing efficiency at the A site of 
serotonin receptor in brains of depressed suicide victims as well as an 
increased editing at the E site in individuals with major  depression 
(Niswender, Herrick-Davis et al. 2001; Gurevich, Tamir et al. 2002; Iwamoto 
and Kato 2003). 
 
Double stranded RNA binding proteins (dsRBPs) 
The common feature of double stranded RNA binding proteins is their 
evolutionarily conserved RNA binding domain which has been first 
identified in the Xenopus laevis RNA-binding protein A (XlrbpA) and the 
Drosophila maternal effect protein Staufen. They have the ability to bind to 
double stranded RNAs and have an important role in some biological 
processes like for example RNA editing, RNA localization, RNA interference 
and RNA processing ( reviewed in (Doyle and Jantsch 2002; Saunders and 
Barber 2003)).  
Most of the double stranded RNA binding proteins contain multiple dsRBDs 
but also proteins with single dsRBDs do exist. dsRBDs have different 
affinities for dsRNA in vitro, furthermore some of them are actually 
incapable of binding to it (Krovat and Jantsch 1996). They have a length of 
approximately 70 amino acids shaping a conserved α-β-β-β-α protein 
topology in which the two α-helices are packed along the face of a three 
stranded antiparallel β-sheet (Bass, Hurst et al. 1994; Bycroft, Grunert et 
al. 1995). 
There are some ways how RNA binding occurs. In seeking to establish these 
mechanisms, the structures of the second dsRBD of XlrbpA (Ryter and 
Schultz 1998), the third dsRBD of Staufen (Ramos, Grunert et al. 2000) and 
the dsRBD of Rnt1p, an RNAse III homologue from budding yeast (Wu, 
Henras et al. 2004) have been determined in complex with RNA. 
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On the one hand the crystal structure of the dsRBD of XlrbpA revealed that 
there is no direct base contact in the interaction between dsRBD and the 
sugar phosphate backbone, therefore proposing a lack of sequence specificity 
(Ryter and Schultz 1998). On the other hand there are a lot of dsRBDs that 
have been shown to bind specifically on dsRNA in vivo and in vitro, for 
example ADAR1 and ADAR2 bind in vivo only a selected group of 
substrates, or Staufen association with bicoid mRNA, which was one of the 
first to show the direct interaction between a dsRBD and RNA and the 
formation of a ribonucleoprotein particle (RNP) (Ferrandon, Elphick et al. 
1994; Wagner, Palacios et al. 2001). Additionally a surprising discovery as 
mentioned above was that not all dsRBDs are able to bind RNA (Krovat and 
Jantsch 1996).  
Through their ability to bind a wide array of different dsRNAs, they can 
accomplish a large number of different functions.  
Drosophila Staufen plays a fundamental role in the formation of the 
anterior- posterior axis, through the localization of the maternal mRNAs 
oskar and bicoid, moving the first one from the anterior to the posterior pole 
of the oocyte and anchoring the later one at the anterior end of the 
developing embryo by binding to e stem loop on its 3`-UTR (Ferrandon, 
Elphick et al. 1994; Wagner, Palacios et al. 2001). The third of the five 
dsRBD of the Staufen is crucial for the RNA binding and its role 
afterwards(Ramos, Grunert et al. 2000). 
RNA-dependent human protein kinase (PKR) is an important element in the 
cellular defense mechanism against virus infection. Its activation through 
the binding of the viral dsRNA to its two dsRBDs, causes it to phosphorylate 
the translation factor eIF2α, leading to a protein synthesis inhibition in the 
cell (Meurs, Chong et al. 1990; Green and Mathews 1992). 
Additionally to the functions after binding dsRNA, dsRBD proteins show 
also other functions that are RNA binding independent. The dsRBD2 of 
Staufen, is responsible for microtubule-dependent localization of Oscar 
mRNA whereas dsRBD5 is needed for its translational control, and both of 
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them are the only dsRBDs which do not bind dsRNA in vitro (reviewed in 
Doyle and Jantsch 2002). 
 
            
 
Figure 3: Double-stranded RNA recognition by double-stranded RNA-binding 
domains  
(Stefl, Skrisovska et al. 2005).          
(A) The double-stranded RNA-binding domain (dsRBD) of Xlrbpa2 bound to dsRNA (Ryter 
and Schultz 1998). In red is shown the α-helix 1, which together with β1-β2 loop and 
the aminoterminal part of α-helix 2, recognize the shape of double stranded RNA. In 
blue and light blue are coloured the backbones of two coaxial duplexes. 
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(B) The dsRBM of Rnt1p bound to the stem–loop closed by the AGNN tetraloop (Wu, 
Henras et al. 2004). Backbone is highlighted in yellow, basis in black whether α-helix 1 
in red. The additional carboxy-terminal α-helix 3 of the dsRBM of RNT1p modulates the 
conformation of α-helix 1 (Leulliot, Quevillon-Cheruel et al. 2004). 
 
 
Nuclear import and export 
The nuclear envelope of all eucaryotes is perforated by structures known as 
nuclear pore complexes (NPCs), which are composed of aproximately 30 
different proteins, nucleoporins, present in multiple copies disposing an 
octagonal symmetry, representing the sites of movement between the 
nucleus and cytoplasm (Rout and Aitchison 2000). 
The nuclear pore complex runs through the nuclear membrane forming a 
channel and manages the nucleocytoplasmic transport of mebrane proteins 
(King, Lusk et al. 2006), soluble proteins (Suntharalingam and Wente 2003)  
and different types of RNAs (Franke and Scheer 1974; Gorlich and Kutay 
1999; Vinciguerra and Stutz 2004). The central channel is aproximately 
30nm in diameter and allows the passive diffusion of ions and proteins with 
a molecular mass up to 40 kDa. The major part of the macromolecules 
perform their transport through the NPC, using an energy-dependent 
mechanisem mediated by transport receptors that belong to a family of 
proteins known as β-karyopherins (Mosammaparast and Pemberton 2004). 
Β-karyopherins accomplish nuclear import and export of membrane 
proteins, some RNAs and ribosomal subunits (Kohler and Hurt 2007). The 
β-karyopherins that mediate nuclear import are called importins and those 
involved in the nuclear export are called exportins.  
The destination of the cargo protein is defined by the interaction of the 
transport receptors with motifs present in the cargo called nuclear 
localisation signal (NLS) or nuclear export signal (NES) (Kohler and Hurt 
2007).  
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The GTPase Ran is a monomeric G-protein that mediates the direction of 
the nucleocytoplasmic transport. It is present in the cytoplasma as well as 
in the nucleus and exists in two conformational states depending whether 
bound to GTP or GDP. Because the hydrolysis of GTP through Ran is very 
slow, the interaction with regulatory proteins regulates its nucleotide 
binding. External factors like Ran-GTPase activating protein (Ran-GAPs) 
and Ran binding protein 1 (Ran BP1) mediate the hydrolysis from GTP to 
GDP. A conformational change is triggered through the binding of RanBP1 
to RanGTP, that allows RanGAP to hydrolyze GTP (Conti and Izaurralde 
2001).While RanGAP and Ran BP1 are exclusively located in the cytoplasm, 
guanine nucleotide exchange factors (GEFs) are only located in the nucleus 
that exchange GTP for GDP. The generation of the gradient over the nuclear 
membrane through the asymmetrical distribution of Ran regulatory 
proteins establishes the directionality of the nucleocytoplasmic transport 
(Gorlich, Seewald et al. 2003). 
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Figure 4: Nucleocytoplasmic transport 
(a) Represented are nucleocytoplasmic import (left) and export (right). (b) Ran 
mediated directionality of the nucleocytoplasmic transport (Atlas of Genetics and 
Cytogenetics in Oncology and Haematology (atlasgeneticsoncology.org)). 
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(a) After binding of importin to the nuclear localization signal of the cargo protein in the 
cytoplasm follows the interaction with NPC to mediate the translocation of the 
complex. The importin Ran-GTP complex in the nucleus lead to the release of cargo. 
The newly formed complex is further recycled to the cytoplasm. The translocation of 
the cargo protein from the nucleus to the cytoplasm takes place after binding of its 
nuclear export signal to the exportin, which is stimulated by RanGTP. In the cytoplasm 
in consequence of removal of GTP from the complex by GTP hydrolyses, exportin 
dissociates from the cargo and is back recycled to the nucleus. 
(b) In the nucleus a high concentration of Ran GTP results after exchange from RanGDP to 
RanGTP by chromatin bound RCC1, which is a nucleotide exchange factor for Ran 
(RanGEF). Maintenance of a low concentration of Ran GTP after importin- RanGTP 
translocation is mediated by RanGTP-binding proteins and RanGAP. 
 
Nuclear transport of hsADAR1 
Beside protein cargos, different types of RNA represent another group of 
export cargos (Lei and Silver 2002). Two exportins bind RNA directly, 
exportin-t which recognize a nuclear export signal in tRNAs mediate its 
export from the nucleus and exportin-5 which recognize an RNA hairpin 
structure with a 3´overhang mediate mRNA precursors export (Arts, 
Kuersten et al. 1998; Kutay, Lipowsky et al. 1998; Kim 2004). Some factors 
involved in the mRNA export are also involved in mRNA transcription, 
processing and splicing indicating that these processes are strictly linked 
(Lei and Silver 2002). 
A number of pri-miRNAs have been shown to be edited either by ADAR1 or 
ADAR2 (Yang, Chendrimada et al. 2006). ADAR1 which shuttles between 
nucleus and cytoplasm could be involved in the transport of the RNA 
substrates over the nuclear membrane (Strehblow, Hallegger et al. 2002). 
The control of the nuclear concentration of this enzyme could regulate its 
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nuclear transport, and as a consequence of that hyperediting might be 
prevented. 
As was mentioned above the human RNA-editing enzyme ADAR1 is 
expressed in the longer 150kDa, interferon inducible version and in the 
amino-terminally truncated 110kDa version. The first one ADAR1i is 
nuclear and cytoplasmic while the second one ADAR1c is predominantly 
nuclear (Patterson and Samuel 1995). Even though ADAR1c lacks a NES it 
is able to shuttle between nucleus and cytoplasm (Strehblow, Hallegger et 
al. 2002). It was shown that the NLS overlaps the third dsRBD of ADAR1c, 
and that transportin-1 is required for the nuclear import of ADAR1 (Fritz, 
Strehblow et al. 2009). Different dsRBD constructs were used to test the 
influence of RNA binding on the interaction between them and TRN1, what 
leads to the conclusion that dsRNA binding inhibited interaction between 
TRN1 and dsRBD3 of ADAR1 (Fritz, Strehblow et al. 2009). Furthermore it 
was shown that exportin-5 also interacts with the dsRBDs interfering with 
TRN1 for dsRBD binding and suggesting a dual role for dsRBD as a nuclear 
import and export signal (Fritz, Strehblow et al. 2009). 
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Figure 5: A model of ADAR1 nucleocytoplasmic shuttling in a dsRNA-dependent 
way 
(Fritz, Strehblow et al. 2009). TRN1 binds ADAR1 in the cytoplasm and transports it to 
the nucleus, where it is released by RanGTP binding. Nuclear export is then mediated 
through the interaction between Exp-5 and one or multiple dsRBDs in a Ran-GTP-
dependent manner. Once arrived in the cytoplasm RanGTP is hydrolysed to RanGDP, 
releasing the complex. The presence of dsRNA precludes the interaction of dsRBD3 
with TRN1 preventing the reimport of ADAR1 bound to RNA. 
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Aim of the thesis 
 
The aim of the thesis was to characterize, determining the three 
dimensional structure, the third double stranded RNA binding domain of 
the human adenosine deaminases that act on RNA (hADAR1c). 
It has been shown that the third dsRBD of ADAR1 is essential for both RNA 
binding as well as for enzyme activity. While the longer version hADAR1i 
has the ability to shuttle between nucleus and cytoplasm very likely because 
of the presence of both nuclear localization signal and nuclear export signal, 
the shorter N-terminal truncated version ADAR1c lacking the NES is 
predominantly nuclear. Additionally it has been shown, that the NLS of 
ADAR1c overlaps its third dsRBD, and that transportin-1 binds ADAR1 
through this domain and is able to import hADAR1-dsRBD3 to the nucleus 
in a RanGTP dependent manner without the need of additional factors. 
Furthermore, dsRBD1 and the presence of dsRNA show an inhibitory effect, 
because in the first case TRN1 cannot mediate the nuclear import of 
dsRBD1+3 and in the second case TRN1 and dsRBD3 are able to interact 
only if dsRNA is absent.  
A three-dimensional structure of dsRBD3 of ADAR1c and further on a 3D 
structure of this domain bound by RNA could probably provide insights, on 
how this interaction exactly occurs and help by finding out control 
mechanisms for its transport. 
Nuclear magnetic resonance spectroscopy (NMR) is a method used to 
analyze three dimensional structures. For this purpose a high protein 
concentration is needed. From previous experiments, we know that the third 
dsRBD of ADAR1c is hardly soluble or more specifically only a low 
concentration is achieved in solution. 
In trying to increase the solubility and consequently the concentration of 
this protein, we made forty constructs that differed in C- and N-termini 
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length. These constructs were tested using different buffers, pH, 
temperatures, and culture growing conditions to find out the most promising 
candidate and also the best conditions in which this construct is highly 
soluble.  
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Materials and Methods 
 
Competent bacterial strains  
For cloning, Escherichia coli XL1Blue competent cells were used. These cells 
are endonuclease (endA) and recombination (recA) deficient, consequently 
greatly improving the quality of miniprep DNA and insert stability. 
Escherichia coli BL21 derivatives BL21 (DE3) and in later experiments 
Rosetta C41 were used for protein expression. They allow high efficiency 
protein expression of any gene that is under the control of a T7 promotor. 
 
Media 
The bacteria are grown in a rich medium (2xTY) and to label the protein 
with 15N a minimal medium (M9) was used. 
 
 
 
 
 
 
 
 
 
TY Medium (pH=7,4) 
Chemicals Weight 
Tryptone 16g 
Yeast 
extract 
10g 
NaCl 5g 
M9 Medium (1l) 
Chemicals 
(concentration) 
Volume 
M9 Salt (5x) 200ml 
MgSO4 (1M) 2ml 
Glucose (20%) 20ml 
CaCl2 (1M) 0.1ml 
Water 778ml 
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Table 1: TY-medium, M9-medium and M9-salt. 
 
Forty-two different constructs of dsRBD3- hADAR1 
To generate different lengths of dsRBD3, different primers were designed, 
containing BamHI (GGA TCC) and HindIII (AAG CTT) restriction sites 
which are also present in the multiple cloning sites (MCS), downstream of 
the T7 promotor in cloning vector pRSETA (MJ109) and pET30(MJ..). 
Vector pRSETA contains a His-Tag and pET30 contains a GB1- domain (56 
amino acid protein) as a solubility-enhancement tags. Further steps and 
methods (shown below) are necessary to get the recombinant DNA, the 
consequent protein expression and purification. 
To amply the specific sequences, polymerase chain reaction was performed. 
 
 
  
M9 Salt 
Chemicals Weight 
Na2PO4 . 2H2O 47g 
KH2PO4 15g 
NH4Cl (15N-
labeled) 
5g 
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Polymerase Chain Reaction (PCR) 
 
 
Polymerase Chain Reaction (PCR) 
Solution 
(concentration) 
Volume 
Template DNA 
(hADAR1GFP; MJ7) 
100ng (1µl of 1:10 
dilution) 
Primer 5` 
100ng (1µl of 1:10 
dilution) 
Primer 3` 
100ng (1µl of 1:10 
dilution) 
dNTP (10mM) 1.5µl 
Buffer 10x 
((NH4)2SO4; -MgCl2) 
5µl 
MgCl2 (25mM) 2.5µl 
Taq Polymerase 0.5µl 
Water dist. 37.5µl 
 25µl total volume 
 
Table 2: Solutions for the polymerase chain reaction. 
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Steps Time Temperature Number of cycles 
Melting 4`30`` 95°C 1 
Annealing 
30`` 50°C 
30 30`` 50°C 
Elongation 
45`` 72°C 
5` 72°C 1 
Table 3: PCR-conditions 
 
For primer sequence and combination see the tables below. 
 
Primer 5‘ Primer 3‘ 
a. MJ2527 
5‘-CAGGATCCATGATGCCCAACAAGGTCA-3‘ 
g. MJ2533 
5‘-GTGGTACCCTAGCGTTCTGCCTTCTCGTTCTC-3‘ 
b. MJ2528 
5‘-CAGGATCCGAATCCATGATGCCCAACAAG-3‘ 
h. MJ2534 
5‘-GTGGTACCCTATGTGAAACCCATGCGTTCTGC-3‘ 
c. MJ2529 
5‘-CAGGATCCAACTTGGAATCCATGATGCCCAAC-3‘ 
i. MJ2535 
5‘-GTGGTACCCTAGGTTACCTCTGTGAAACCCAT-3‘ 
d. MJ2530 
5‘-CAGGATCCCTTGATAACTTGGAATCCATGATG-3‘ 
j. MJ2536 
5‘-GTGGTACCCTATGTCACTTGGGTTACCTCTGT-3‘ 
e. MJ2531 
5‘-CAGGATCCGAGTCACTTGATAACTTGGAATCC-3‘ 
k. MJ2537 
5‘-GTGGTACCCTAACTGGCCCCTGTCACTGGGGT-3‘ 
f. MJ2532 
5‘-CAGGATCCTCAGAGTCACTTGATAACTTGGAA-3‘ 
l. MJ2538 
5‘-GTGGTACCCTATCTGAGACTGGCCCCTGTCAC-3‘ 
Table 4: Primer designed for the different constructs. 
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Constructs 1-36 ( in pRSETA) - Primer combination 
1 - ag 7 - bg 13 - cg 19 - dg 25 - eg 31 - fg 
2 - ah 8 - bh 14 - ch 20 - dh 26 - eh 32 - fh 
3 - ai 9 - bi 15 - ci 21 - di 27 - ei 33 - fi 
4 - aj 10 - bj 16 - cj 22 - dj 28 - ej 34 - fj 
5 - ak 11 - bk 17 - ck 23 - dk 29 - ek 35 - fk 
6 - al 12 - bl 18 - cl 24 - dl 30 - el 36 - fl 
 
Construct 
 
Primer combination 
5‘ 3‘ 
A 
MJ2695 
5‘-CTGGGATCCGAGGCGACCAACTCCATG-3‘ 
MJ2683 
5‘-GCTAAGCTTCTCAGGACCTTGAGAGGAGGAGC-3‘ 
B 
MJ2527 
5‘-CAGGATCCATGATGCCCAACAAGGTCA-3‘ 
MJ2683 
5‘-GCTAAGCTTCTCAGGACCTTGAGAGGAGGAGC-3‘ 
C 
MJ2695 
5‘-CTGGGATCCGAGGCGACCAACTCCATG-3‘ 
MJ2533 
5‘-GTGGTACCCTAGCGTTCTGCCTTCTCGTTCTC-3‘ 
E 
MJ2527 
5‘-CAGGATCCATGATGCCCAACAAGGTCA-3‘ 
MJ2763 
5‘-GGGTTCCGCGCACATTTCCCCG-3‘ 
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Const
ruct 
Primer combination 
5‘ 3‘ 
N13 
MJ2529 
5‘-CAGGATCCAACTTGGAATCCATGATGCCCAAC-3‘ 
MJ2735 
5‘-GGTGGATCCGCGTTCTGCCTTCTCGTTCTC-3‘ 
NB 
MJ2527 
5‘-GGTGGATCCGCGTTCTGCCTTCTCGTTCTC-3‘ 
MJ2737 
5‘-GCTGGGATCCTGGGGACCTTGAGAGGAGGAG-3‘ 
Table 5 : Primer combination 
 
Restriction Digest 
Restriction digestion was performed in a total volume of 20µl. Master Mix, 
including restriction enzyme and corresponding buffer, was prepared on ice. 
DNA was added to the Master Mix aliquots and incubated usually for 1,5 
hour at 37°C. 
 
 
 
 
 
 
 
. 
Solution Volume 
DNA 5µl 
Restriction 
enzyme 
1µl 
Buffer 2µl 
RNase/BSA 2µl 
Water dist. 10µl 
 20µl total 
 
 
 
 
 
 
 
 
 
 
Table 6: Solutions for the restriction digest. 
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Gel elektrophoresis  
To test if PCR, restriction, ligation, or minipreps have properly functioned, 
DNA was separated on agarose gels of 0.5-2% depending on fragment sizes. 
Agarose was solubilised in 1x TAE buffer (2M Tris, 1M NaAc, 50mM EDTA, 
pH=7.4). Samples were mixed with 6x loading buffer and loaded onto the 
gel. As a running buffer was used 1x TAE and gels were run at constant 
voltage of 70V until the desired separation was achieved. 
 
Ligation and Transformation 
For the ligation, a ratio of 1 vector to 3 inserts was used.  Vector, insert, 
ligase, appropriate ligase buffer and distilled water were mixed at a total 
volume of 20µl. After that, the tubes were put usually in the 16°C incubator 
over night. 
 For transformation, aliquots of frozen cells were thawed on ice. After 
addition of plasmid DNA, the mixture remained on ice for at least 15 
minutes. A subsequent 90-second heat shock at 42°C was followed by the 
addition of SOB medium. Cells were incubated in a 37°C shaker for 1 hour, 
than plated on Luria Bertani (LB) - Agar with the appropriate antibiotic to 
maintain plasmid selection, and afterwards the plates were incubated 
overnight at 37°C. 
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Isolation of Plasmid DNA 
To extract and purify plasmid DNA mini- and midi-preparation`s protocols 
were used. 
For minipreps, were used cells, which were span 10 minutes at 3.000 rpm 
after an overnight inoculation of colonies in 3ml TY medium (one colony/ 
3ml Medium) with appropriate antibiotic. The supernatant was discarded, 
cell pellet resuspended in 200µl GTE (Glucose/Tris/EDTA), transferred in 
fresh eppendorf tube and incubated 5 minutes at room temperature. After 
adding 400µl alkaline SDS (1% SDS/ 0.2M NaOH), the tubes were inverted 
several times and incubated 5 minutes on ice. The next steps after adding 
300µl KAc were to mix them, to leave them 5 minutes on ice and to spin 5 
minutes at 14.000 rpm. Supernatant was transferred in fresh eppendorf 
tube and 700µl 2-propanol was added. A subsequently 10-20 minutes 
incubation at -20°C was followed by 5-10 minutes spinning at 14.000 rpm. 
The pellet was dissolved in 200µl water and 200µl 5M NH4Ac was added. 
After shaking 5-10 minutes and spinning 5 minutes at 14.000 rpm, the 
supernatant was transferred again in fresh eppendorf tube and 1ml 96% 
EtOH was added. The incubation at -80°C for 30 minutes (or overnight at -
20°C) is followed by spinning for 5 minutes at 14.000 rpm. The pellet was 
washed with 50µl 70% EtOH, span 5 minutes at 14.000, dried and dissolved 
in 50µl distilled water. 
 
DNA Extraction 
To the isolated DNA was added 1µl RNAse A and was incubated for 15 
minutes at 37°C.  Addition of 50µl 1x TE (minimal total volume: 100µl) and 
50µl phenol was followed by a vigorous vortex and 5 minutes spinning at 
14.000 rpm. The supernatant was transferred in a fresh eppendorf tube, 
50µl PCI (Phenol/ Chloroform/ Isoamylalcohol) was added and again vortex 
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and spinning 5 minutes at 14.000 rpm are done. This step was repeated 
with CI (Chloroform/ Isoamylalcohol) and after transferring the supernatant 
in a fresh eppendorf tube, 10µl NaOAc (1/10 Vol.) and 300µl 96% EtOH (3 
Vol.) was added and mixed. The last two steps include the incubation at -
80°C for 2 hours (or at -20°C overnight) and the DNA precipitation. 
 
Cycle Sequencing 
To check if the recombinant DNA contains the proper sequence, Biotech 
PCR-Machine was used to perform cycle sequencing. 
 
Solution 
(concentration) 
Volume 
DNA           
(500ng/µl) 
1µl 
Primer     
(0.8pMol/µl) 
4 µl 
Buffer  (2.5*) 1 µl 
Big dye 1 µl 
Water dist. 3 µl 
 10 µl total 
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PCR Program (cycle sequencing) 
1. 
Rapid thermal ramp to 96°C 
 
2. 
96°C for 10” 
 
3.  for 25 
cycles 
Rapid thermal ramp to 50°C 
4. 
50°C for 5” 
 
5. 
Rapid thermal ramp to 60°C 
 
6. 
60°C for 4` 
 
Table 7: Solutions and PCR-program used for the cycle sequencing 
 
 
SDS-polyacrylamid gel electrophoresis  (SDS PAGE)  
Before loading the samples onto the gel to separate them according to their 
size, the proteins were denatured mixing them at first with 2x SDS sample 
buffer (220mM Tris-HCl pH 6.8, 1.8% SDS, 29% glycerol, 0.03% 
bromophenol-blue, 0.03% β-mercaptoethanol) and then by boiling them for 5 
minutes at 96°C. 
After preparing the minigel apparatus (1cm spacer), the separation gel was 
mixed (values for 13% gel): 
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Solutions 
(concentration) 
Volume 
30% Acrylamide 3ml 
Water distilled 1.3ml 
Tris pH=8.8 (1M) 2.6ml 
SDS 10% 50µl 
APS 10% 50µl 
Temed 15µl 
Table 8: Solutions used for the separation gel (13%) 
 
The gel was cast into the apparatus leaving circa 1.5 cm empty, overlaid 
with isopropanol and allowed to polymerize. Next the loading gel is mixed, 
poured and a comb is placed to create the wells. 
Loading gel: 
 
Solutions Volume 
Acrylamide 
(Stock) 
4ml 
APS 10% 35µl 
Temed 10µl 
Table 9: Solutions used for the loading gel. 
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After the loading gel is polymerized, the apparatus was placed into 
electrophoresis tank, filled with 1x SDS running buffer (25mM Tris-HCl, 
190mM glycine, 0.1% SDS), and then the comb was removed.  After loading 
the protein extracts (10µl), the gel was run with 25mA/gel until the sample 
buffer dye reached the bottom. 
 
Western Blotting  
To perform western blotting a polyvinylidene fluoride membrane (GE Water 
& Process Technologies), activated in methanol and equilibrated in transfer 
buffer (20mM Tris-HCl, 150mM glycine), was placed on the gel on which the 
proteins are separated after electrophoresis and all air bubbles were 
removed. The gel and membrane were placed between two Whatman papers 
and two sponges, and that sandwich was then put into the tank, which was 
filled up with transfer buffer. The transfer was carried out at room 
temperature with icepacks in the apparatus at 360-450mA for 80 minutes. 
Next, the membrane was washed with 0.5% milk in TBST (25mM Tris, pH 
7.4, 3.0mM KCl, 140mM NaCl and 0.05% Tween 20) and then blocked with 
5% dry skim milk in TBST for 10 minutes at room temperature. The only 
one antibody used (AP + Ni-NTA-AB) was diluted in 0.5% milk in TBST (1: 
1000), applied to the membrane and incubated for one hour at room 
temperature. Next, it was washed three times each 5 minutes with 0.5% 
milk in TBST, and after mixing the APB with 33µl BCIP (5-Bromo-4-Chloro-
3'-Indolyphosphate p-Toluidine Salt) and 66µl NBT (Nitro-Blue Tetrazolium 
Chloride) it was incubated for 30 minutes at room temperature. Then the 
membrane was washed two times with water and let dry on paper 
overnight. The protein on the blot was detected by NBT/BCIP chromogen 
precipitation. NBT/BCIP together, when reacted with Alkaline Phosphatase 
yield an intense, insoluble black-purple precipitate. 
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Expression and purification of recombinant protein 
Escherichia coli BL21 (DE3) or Rosetta (C41) strain harboring either 
pRSETA or pET30 vector encoding for His- or GB1-fusion protein were 
grown in 50-100ml cultures with the appropriate antibiotic at 37°C. At an 
OD600 (optic density) of about 0.7 the expression of the protein dsRBD3 was 
induced by addition of isopropyl-β-D-thiogalactopyranoside (IPTG) to a final 
concentration of 1mM. After 3 hours induction the cells were harvested by 
centrifugation at 14.000rpm for 10 minutes. Cell pellet was resuspended in 
lysis buffers and further lysed and sonicated as shown in the three steps 
below: 
Step one: lysis with 10mM KI, 20mM KH2PO4 + K2HPO4, 0.1% triton, 
1mM DTT, sonication for 5 minutes, centrifugation for 10 minutes at 
14000rpm. 
Step two: lysis with 150mM KI, 20mM KH2PO4 + K2HPO4, 0.1% triton, 
1mM DTT, sonication for 5 minutes, centrifugation for 10 minutes at 
14000rpm. 
Step three: lysis with 1M KI, 20mM KH2PO4 + K2HPO4, 0.1% triton, 1mM 
DTT, sonication  for 5 minutes, centrifugation for 10 minutes at 14000rpm. 
 The supernatants were loaded into a Ni-NTA column at room temperature. 
The column was washed with a buffer containing 10mM imidazol, 150mM 
KI, 0.1% triton and 1mM DTT at the first step, whether at the second step 
the washing buffer contained 50mM imidazol, 150mM KI, 0.1% triton and 
1mM DTT. The protein was then eluted in fractions of about 500µl volume, 
with a buffer containing 500mM imidazol, 150mM KI, 0.1% triton and 1mM 
DTT. The protein was dialysed in four steps, each for 2 hours. Thereby it 
was also denatured and slowly renatured by stepwise dilution of guanidine 
hydrochloride, using the buffers below: 
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First step: 6M guanidine hydrochloride, 150mM KI, 20mM K2HPO4 + 
KH2PO4 (pH=7.2), 1mM DTT. 
Second step: 3M guanidine hydrochloride, 150mM KI, 20mM K2HPO4 + 
KH2PO4 (pH=7.2), 1mM DTT. 
Third step: 1mM guanidine hydrochloride, 150mM KI, 20mM K2HPO4 + 
KH2PO4 (pH=7.2), 1mM DTT. 
Fourth step: 150mM KI, 20mM K2HPO4 + KH2PO4 (pH=7.2), 1mM DTT. 
The protein concentration was then measured using Bradford assay. 
 
Bradford assay 
Bradford dye concentrate was diluted with distilled water at a ratio 1:5.  
To determine the protein concentration a standard curve was created using 
5 cuvettes within 1ml Bradford solution and the following amounts of BSA 
(bovine serum albumin): 0 (baseline), 1.25, 2.5, 5, 10 micrograms. In an 
additional cuvette 1ml Bradford solution was mixed with 1µl of the protein, 
of which concentration was going to be determined. Finally a 
spectrophotometer was used to measure the OD (optical density) at 595nm. 
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Results 
 
In this work, nuclear magnetic resonance spectroscopy (NMR) (implemented 
by Pierre Barraud, in the laboratory of Prof.Dr. Frederic Allain, from the 
institute for molecular biology and biophysics in Zurich) was used to obtain 
the resolution of the three dimensional structure of the protein which in 
contrast to X- Ray, is applied mainly for small proteins, usually smaller 
than 35kDa. The application of NMR requires, protein sample to be well-
behaved and non-aggregated sample to be at an adequate high protein 
concentration. Since the whole dsRBD3 protein is only partially soluble and 
not nearly sufficient for applying NMR, constructs with different lengths 
were made trying to include in the protein sequence as few as possible 
nonpolar (hydrophobic) aminoacids. Additionally different buffers, pH 
values, temperatures and incubations times were tested to find out the best 
conditions on which the protein behaves at best for NMR purpose. 
 
Purification of His-tagged dsRBD3 
The first 36 constructs (1-36) and the four following ones termed A, B, C, 
and E of dsRBD3 were recombinantly expressed in pRSETA with a His-Tag 
which was fused to the protein C-terminal. A Ni-NTA column was used for 
affinity purification. The constructs were made so that the first six have the 
same N-Terminus but with a progressively extending C-Terminus. The next 
six have a longer N-Terminus compared to the first 6 constructs but the C-
Terminus has the same progressive extension, and so on. The constructs 1-
36 are made the way shown schematically below. 
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                   5’ Primer                                         3’ Primer  
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Constructs 1-36 of dsRBD3 done extending either the N- or the C-
Terminus 
            Additionally, the length of the constructs termed A, B, C and E show a 
relation as in the scheme below. 
 
 
 
Figure 7: Schema of dsRBD3 constructs termed A, B, C and E 
. 
 
           After protein expression as described above, the cell pellet was lysed in 
three steps with lyses buffer containing first 10mM NaCl, hepes pH=7.4, 
0.1% triton, then 100mM NaCl, hepes (pH=7.4), 0.1% Triton, and finally 1M 
NaCl, hepes (pH=7.4), 0.1% Triton. Between the steps the lysate was 
sonicated for 4 minutes and centrifuged for 5 minutes at 14000rpm to obtain 
the pellet for the next lyses step. The supernatant gained at the end was 
washed and eluted from the Ni-NTA column, using for the washing 100mM 
imidazol, 1XPBS (1.37M NaCl, 27mM KCl, 43mM Na2PO4, 14mM 
KH2PO4, pH=7.4), 1%triton, and for elution 500mM imidazol, 1XPBS and 
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1% triton. Initially Flow pressure liquid chromatography (FPLC) at 4°C was 
performed. Trying to improve the conditions, the lysate was in the further 
experiments manually loaded onto the Ni-NTA column at room temperature 
showing that experiments carried out in this temperature gives better 
results as at a lower temperature of  4°C. 
                                  
Figure 8: Purification of His- tagged construct number 13 using FPLC at 4°C 
             Shown are FPLC- fractions (lane 1-7), supernatant before loading into FPLC (lane 9) 
and pellet (lane 10) before purification. 
                                 
Figure 9: Purification of His-tagged construct number 13 using Ni-NTA column 
manually at room temperature 
After elution with 500mM Imidazol 10µl of each fraction are loaded. 
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           To optimize the expression level of the protein, expression-time and 
induction-period were among others also tested (constructs lettered A, B 
und C). 
               a     b    
 
                  c     
Figure 10: Different incubation and induction times tested on construct A, B and 
C. 
             (a) A1, B1, C1 cultures were incubated for 4 hours and inducted for 2 hours, whether 
A2, B2, C2 cultures were incubated for 6 hours and inducted for 2 hours. (b) A3, B3, C3 
cultures were inducted overnight after 4 hours incubation, whether A4, B4, C4 were 
also inducted overnight but incubated for 6 hours. (c) A5, B5, C5 and A6, C6 were 
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incubated overnight, but the first three were inducted for 2 hours whether the last two 
for 4 hours. 
           We performed the cell growth and protein induction almost always for about 
7 hours incubation and 3 hours induction when cells were grown in TY 
medium. Cells grown in minimal medium (M9) need a much longer 
incubation time of about 24 hours to reach an optical density of about 0.7. 
 
         a   b  
Figure 11: Solubility test of A, B, C- constructs. 
            (a) Lanes 1-3 show the supernatant of constructs A,B,C after lysis with 10mM NaCl, 
hepes pH=7.4, 0.1% triton whether in the lanes 4-6 are loaded supernatants after lysis 
with 100mM NaCl, hepes pH=7.4, 0.1% triton and in lanes 7-9 after lysis with 1mM 
NaCl, hepes pH=7.4, 0.1% triton. (b) Lanes 1-3 show the pellet remained after lysis with 
1mM NaCl, hepes pH=7.4, 0.1% triton. As shown in lanes 7-9 (a) the best result is 
obtained from the lysis with the buffer containing 1mM NaCI. 
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Purification of GB1-tagged dsRBD3 
 GB1 (immunoglobulin G binding domain 1 of Streptococcal protein G) is a 
solubility enhancement tag (SET), a 56 amino acid protein highly stable and 
soluble. 
We apply GB1- tag because the most known protein tags, such as MBP 
(Maltose Binding Protein) or GST (Gluthation-S-Transferase) have a large 
size, which hinders the structural characterization of a fusion protein by 
NMR. Additionally cleavage of the fusion proteins often re-introduces 
problems with solubility and stability (Zhou, Lugovskoy et al. 2001). 
The two best dsRBD3 constructs among the forty described above, construct 
13 and B were fused with GB1-tag, and termed N13 and NB. 
Cell-pellets containing this constructs were lysed with a different buffer as 
the constructs described above, which contains KI instead of NaCl. The 
washing buffer contains also KI instead of NaCl. After lysis with 150mM KI, 
10mM hepes pH=7.4, 0,1% triton and centrifugation, supernatant was 
manually loaded into the Ni-NTA column and after two steps washing with 
10mM imidazol, 150mM KI, 0.1% Triton and 50mM imidazol, 150mM KI, 
0.1% triton, was eluted with 500mM imidazol, 150mM KI, 0.1% triton. 
After that, dialysis was performed for 4 hours. Dialysis solution contained: 
150mM KI, 20mM K2HPO4 + KH2PO4 (pH=7,2), 1mM DTT ( 
Dithiothreitol). 
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      a  
 
             b  c     
Figure 12: Purification of clones grown in different media and dialysis. 
            (a) Purification of clone N13, grown in TY rich medium. Shown are: supernatant 
before loading into the column (lane 1), flow (lane2), first wash step with 10mM 
imidazol (lane 3), second wash step with 100mM imidazol (lane4), N13 fractions (lane 
6-8). (b) Purification of clone N13, grown in M9 minimal medium. Shown are like in 
figure (a), supernatant, flow, washing steps and the fraction after elution. (c) 
Fractions after dialysis 
 
The last experiments were performed using the lysis buffer mentioned in 
the materials and method part. This buffer contained 20mM KH2PO4 + 
54 
K2HPO4 (pH=7,2) instead of hepes and 1mM DTT was added. Dialysis was 
carried out with a gradient of guanidine hydrochloride in addition to 150mM 
KI, 20mM KH2PO4 + K2HPO4 (pH=7,2), 1mM DTT. 
a   b  
  c   d  
Figure 13: Purificaton of different clones of construst NB. 
In all pictures is shown: supernatant before purification (lane 1), flow (lane2), first and 
second wash step ( lane 3 and 4), eluted fractions (lane 5-9) 
55 
                                    
Figure 14: Clone N13 after dialysis. 
Fractions with a large amount of protein were singly dialysed. 
 
Nuclear magnetic resonance (NMR) spectroscopy 
After dialysis the protein concentration was measured: the highest protein 
concentration reached was 6,4 µg/µl. Further on the protein-samples were 
send to institute for molecular biology and biophysics (Prof.Dr. Frederic 
Allain, Pierre Barraud) and nuclear magnetic resonance spectroscopy was 
applied. 
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  a  
          b  
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  c  
 d  
Figure 15: NMR-spectroscopy spectra. 
 (a) 1D spectrum of clone N13 (b) 2D 15N-1H-HSQC spectrum of clone N13 (c) 1D 
spectrum of clone NB (d) 2D 15N-1H-HSQC spectrum of clone NB 
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On the first 1D spectrum we can see buffer lines and therefore we changed 
the buffer conditions and switched from hepes to potassium phosphate-
buffer. On the 2D spectra there are about 60 amide signals coming from the 
backbone of GB1 tag, and additional peaks coming from the GB1 side chain. 
From the domain come only some additional weak peaks. It could be that 
there was an aggregation problem or the domain was not folded, or both, not 
folded and aggregated. Therefore further experiments are necessary to 
obtain the 3D structure of this protein. 
 
Nucleotide sequence of construct N13 (495bp) 
ATGCAGTACAAACTGATCCTGAACGGTAAAACCCTGAAAGGTGAAAC
CACCACCGAAGCTGTTGACGCTGCTACCGCGGAAAAAGTTTTCAAAC
AGTACGCTAACGACAACGGTGTTGACGGTGAATGGACCTACGACGA
CGCTACCAAAACCTTCACCGTTACCGAAGGATCCAACTTGGAATCCA
TGATGCCCAACAAGGTCAGGAAGATTGGCGAACTCGTGAGATACCTG
AACACCAACCCTGTGGGTGGCCTTTTGGAGTACGCCCGCTCCCATGG
CTTTGCTGCTGAATTCAAGTTGGTCGACCAGTCCGGACCTCCCCACG
AGCCCAAGTTCGTTTACCAAGCAAAAGTTGGGGGTCGCTGGTTCCCA
GCCGTCTGCGCACACAGCAAGAAGCAAGGCAAGCAGGAAGCAGCAG
ATGCGGCTCTCCGTGTCTTGATTGGGGAGAACGAGAAGGCAGAACG
CGGATCCCACCACCACCACCACCACTAA 
 
Amino acid sequence of construct N13  
MQYKLILNGKTLKGETTTEAVDAATAEKVFKQYANDNGVDGEWTYD
DATKTFTVTEGSNLESMMPNKVRKIGELVRYLNTNPVGGLLEYARSH
GFAAEFKLVDQSGPPHEPKFVYQAKVGGRWFPAVCAHSKKQGKQEA
ADAALRVLIGENEKAERGSHHHHHH* 
 
Nucleotide sequence of construct NB (384bp) 
ATGATGCCCAACAAGGTCAGGAAGATTTGCGAACTCGTGAGATACCTG
AACCCCAACCCTGTGGGTGGCCTTTTGGAGTACGCCCGCTCCCATGGC
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TTTGGTGCTGAATTCAAGTTGGTCGACCAGTCCGGACCTCCTCACGAGC
CCAAGTTCGTTTACCAAGCAAAAGTTGGGGGTCGCTGGTTCCCAGCCG
TCTGCGCACACAGCAAGAAGCAAGGCAAGCAGGAAGCAGCAGATGCGG
CTCTCCGTGTCTTGATTGGGGAGAACGAGAAGGCAGAACGCATGGGTT
TCACAGAGGTAACCCCAGTGACAGGGGCCAGTCTCAGAAGAACTATGC
TCCTCCTCTCAAGGTCCCCAGGATCCCACCACCACCACCACCACTAA 
 
Amino acid sequence of construct NB 
MMPNKVRKICELVRYLNPNPVGGLLEYARSHGFGAEFKLVDQSGPPHE
PKFVYQAKVGGRWFPAVCAHSKKQGKQEAADAALRVLIGENEKAERMG
FTEVTPVTGASLRRTMLLLSRSPGSHHHHHH* 
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Discussion 
 
A range of organisms from E.coli to human have proteins which contain      
double stranded RNA binding domains (dsRBDs). They are involved in different 
cellular processes such as RNA-processing, RNA-editing or RNA-localisation. 
On the one hand they bind specifically to A-helices formed by dsRNAs or RNA-
DNA hybrids, on the other hand they can also interact with different cellular 
factors in an RNA-independent manner (St Johnston, Brown et al. 1992; 
Bevilacqua and Cech 1996). It has been shown that dsRBDs can influence 
translational control and also the cellular distribution of their respective 
protein (Doyle and Jantsch 2002; Saunders and Barber 2003) 
The third double stranded RNA binding domain (dsRBD3) of human ADAR1 is 
overlapped by a nuclear localization signal and the NLS activity displayed by 
this domain does not depend on RNA binding indicating a dual function for this 
domain (Eckmann, Neunteufl et al. 2001). ADAR1c has the ability to shuttle 
between the nucleus and cytoplasm even though it lacks a nuclear export 
signal. Transportin-1 (TRN1) was identified as the import receptor for ADAR1 
and it was shown that TRN1 binds hADAR1 via its third dsRBD and that the 
dsRNA binding interfere with transportin-1 binding (Fritz, Strehblow et al. 
2009). The interaction between export factor exportin-5 and each dsRBD in 
ADAR1 is stimulated by RNA-binding and might control nuclear export while 
dsRBD3 can mediate nuclear import (Fritz, Strehblow et al. 2009). It seems 
that after ADAR1 export to the cytoplasm, the nuclear import can occur only 
after the dissociation of the bound RNA which allows TRN1 to bind to the NLS 
in dsRBD3. 
Finding out the three dimensional structure of the dsRBD3 of hADAR1, and 
furthermore that of this domain bound to RNA could provide more information 
about their interaction and the nuclear transport. Information about the 
biological function and the mechanisms linked to the functions as well as 
information on relationships between macromolecules could also be acquired. 
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Appendix 
 
Sequences of the constructs 1-36 and A, B, C, E 
Construct 1 (287bp) 
 1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
atg atg ccc aac aag gtc agg aag att ggc gag ctc gtg aga tac ctg aac acc aac 
cct gtg ggt ggc ctt ttg gag tac gcc cgc tcc  
M   M   P   N   K   V   R   K   I   G   E   L   V   R   Y   L   N   T   N   P   
V   G   G   L   L   E   Y   A   R   S    
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
cat ggc ttt gct gct gaa ttc aag ttg gtc gac cag tcc gga cct cct cac gag ccc 
aag ttc gtt tac caa gca aaa gtt ggg ggt cgc  
H   G   F   A   A   E   F   K   L   V   D   Q   S   G   P   P   H   E   P   K   
F   V   Y   Q   A   K   V   G   G   R    
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
tgg ttc cca gcc gtc tgc gca cac agc aag aag caa ggc aag cag gaa gca gca gat 
gcg gct ctc cgt gtc ttg att ggg gag aac gag  
W   F   P   A   V   C   A   H   S   K   K   Q   G   K   Q   E   A   A   D   A   
A   L   R   V   L   I   G   E   N   E    
271/91                                   
 |                                        
 aag gca gaa cgc atg gg 
 K   A   E   R   M    
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Construct 2 (297bp) 
1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
atg atg ccc aac aag gtc agg aag att ggc gag ctc gtg aga tac ctg aac acc aac 
cct gtg ggt ggc ctt ttg gag tac gcc cgc tcc  
M   M   P   N   K   V   R   K   I   G   E   L   V   R   Y   L   N   T   N   P   
V   G   G   L   L   E   Y   A   R   S    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 cat ggc ttt gct gct gaa ttc aag ttg gtc gac cag tcc gga cct cct cac gag ccc 
aag ttc gtt tac caa gca aaa gtt ggg ggt cgc  
 H   G   F   A   A   E   F   K   L   V   D   Q   S   G   P   P   H   E   P   K   
F   V   Y   Q   A   K   V   G   G   R    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 tgg ttc cca gcc gtc tgc gca cac agc aag aag caa ggc aag cag gaa gca gca gat 
gcg gct ctc cgt gtc ttg att ggg gag aac gag  
 W   F   P   A   V   C   A   H   S   K   K   Q   G   K   Q   E   A   A   D   A   
A   L   R   V   L   I   G   E   N   E    
 
 271/91                                   
 |                                        
 aag gca gaa cgc atg ggt ttc aca gag 
 K   A   E   R   M   G   F   T   E    
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Construct 3 (306bp) 
 
 1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
atg atg ccc aac aag gtc agg aag att ggc gag ctc gtg aga tac ctg aac acc aac 
cct gtg ggt ggc ctt ttg gag tac gcc cgc tcc  
 M   M   P   N   K   V   R   K   I   G   E   L   V   R   Y   L   N   T   N   P   
V   G   G   L   L   E   Y   A   R   S    
91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 cat ggc ttt gct gct gaa ttc aag ttg gtc gac cag tcc gga cct cct cac gag ccc 
aag ttc gtt tac caa gca aaa gtt ggg ggt cgc  
 H   G   F   A   A   E   F   K   L   V   D   Q   S   G   P   P   H   E   P   K   
F   V   Y   Q   A   K   V   G   G   R    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 tgg ttc cca gcc gtc tgc gca cac agc aag aag caa ggc aag cag gaa gca gca gat 
gcg gct ctc cgt gtc ttg att ggg gag aac gag  
 W   F   P   A   V   C   A   H   S   K   K   Q   G   K   Q   E   A   A   D   A   
A   L   R   V   L   I   G   E   N   E    
 
 271/91                                  301/101                                  
 |                                       |                                        
 aag gca gaa cgc atg ggt ttc aca gag gta acc cca 
 K   A   E   R   M   G   F   T   E   V   T   P    
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Construct 4 (314) 
1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 atg atg ccc aac aag gtc agg aag att ggc gag ctc gtg aga tac ctg aac acc aac 
cct gtg ggt ggc ctt ttg gag tac gcc cgc tcc  
 M   M   P   N   K   V   R   K   I   G   E   L   V   R   Y   L   N   T   N   P   
V   G   G   L   L   E   Y   A   R   S    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 cat ggc ttt gct gct gaa ttc aag ttg gtc gac cag tcc gga cct cct cac gag ccc 
aag ttc gtt tac caa gca aaa gtt ggg ggt cgc  
 H   G   F   A   A   E   F   K   L   V   D   Q   S   G   P   P   H   E   P   K   
F   V   Y   Q   A   K   V   G   G   R    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 tgg ttc cca gcc gtc tgc gca cac agc aag aag caa ggc aag cag gaa gca gca gat 
gcg gct ctc cgt gtc ttg att ggg gag aac gag  
 W   F   P   A   V   C   A   H   S   K   K   Q   G   K   Q   E   A   A   D   A   
A   L   R   V   L   I   G   E   N   E    
 
 271/91                                  301/101                                  
 |                                       |                                        
 aag gca gaa cgc atg ggt ttc aca gag gta acc cca gtg aca g 
 K   A   E   R   M   G   F   T   E   V   T   P   V   T    
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Construct 5 (324bp) 
 1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 atg atg ccc aac aag gtc agg aag att ggc gag ctc gtg aga tac ctg aac acc aac 
cct gtg ggt ggc ctt ttg gag tac gcc cgc tcc  
 M   M   P   N   K   V   R   K   I   G   E   L   V   R   Y   L   N   T   N   P   
V   G   G   L   L   E   Y   A   R   S    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 cat ggc ttt gct gct gaa ttc aag ttg gtc gac cag tcc gga cct cct cac gag ccc 
aag ttc gtt tac caa gca aaa gtt ggg ggt cgc  
 H   G   F   A   A   E   F   K   L   V   D   Q   S   G   P   P   H   E   P   K   
F   V   Y   Q   A   K   V   G   G   R    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 tgg ttc cca gcc gtc tgc gca cac agc aag aag caa ggc aag cag gaa gca gca gat 
gcg gct ctc cgt gtc ttg att ggg gag aac gag  
 W   F   P   A   V   C   A   H   S   K   K   Q   G   K   Q   E   A   A   D   A   
A   L   R   V   L   I   G   E   N   E    
 
 271/91                                  301/101                                  
 |                                       |                                        
 aag gca gaa cgc atg ggt ttc aca gag gta acc cca gtg aca ggg gcc agt ctc 
 K   A   E   R   M   G   F   T   E   V   T   P   V   T   G   A   S   L    
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Construct 6 (331bp) 
1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 atg atg ccc aac aag gtc agg aag att ggc gag ctc gtg aga tac ctg aac acc aac 
cct gtg ggt ggc ctt ttg gag tac gcc cgc tcc  
 M   M   P   N   K   V   R   K   I   G   E   L   V   R   Y   L   N   T   N   P   
V   G   G   L   L   E   Y   A   R   S    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 cat ggc ttt gct gct gaa ttc aag ttg gtc gac cag tcc gga cct cct cac gag ccc 
aag ttc gtt tac caa gca aaa gtt ggg ggt cgc  
 H   G   F   A   A   E   F   K   L   V   D   Q   S   G   P   P   H   E   P   K   
F   V   Y   Q   A   K   V   G   G   R    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 tgg ttc cca gcc gtc tgc gca cac agc aag aag caa ggc aag cag gaa gca gca gat 
gcg gct ctc cgt gtc ttg att ggg gag aac gag  
 W   F   P   A   V   C   A   H   S   K   K   Q   G   K   Q   E   A   A   D   A   
A   L   R   V   L   I   G   E   N   E    
 
 271/91                                  301/101                                  
 |                                       |                                        
 aag gca gaa cgc atg ggt ttc aca gag gta acc cca gtg aca ggg gcc agt ctc aga 
aga a 
 K   A   E   R   M   G   F   T   E   V   T   P   V   T   G   A   S   L   R   R    
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Construct 7 (291bp) 
 1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 gaa tcc atg atg ccc aac aag gtc agg aag att ggc gag ctc gtg aga tac ctg aac 
acc aac cct gtg ggt ggc ctt ttg gag tac gcc  
 E   S   M   M   P   N   K   V   R   K   I   G   E   L   V   R   Y   L   N   T   
N   P   V   G   G   L   L   E   Y   A    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 cgc tcc cat ggc ttt gct gct gaa ttc aag ttg gtc gac cag tcc gga cct cct cac 
gag ccc aag ttc gtt tac caa gca aaa gtt ggg  
 R   S   H   G   F   A   A   E   F   K   L   V   D   Q   S   G   P   P   H   E   
P   K   F   V   Y   Q   A   K   V   G    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 ggt cgc tgg ttc cca gcc gtc tgc gca cac agc aag aag caa ggc aag cag gaa gca 
gca gat gcg gct ctc cgt gtc ttg att ggg gag  
 G   R   W   F   P   A   V   C   A   H   S   K   K   Q   G   K   Q   E   A   A   
D   A   A   L   R   V   L   I   G   E    
 
 271/91                                   
 |                                        
 aac gag aag gca gaa cgc atg 
 N   E   K   A   E   R   M    
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Construct 8 (295bp) 
 1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 atg atg ccc aac aag gtc agg aag att ggc gag ctc gtg aga tac ctg aac acc aac 
cct gtg ggt ggc ctt ttg gag tac gcc cgc tcc  
 M   M   P   N   K   V   R   K   I   G   E   L   V   R   Y   L   N   T   N   P   
V   G   G   L   L   E   Y   A   R   S    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 cat ggc ttt gct gct gaa ttc aag ttg gtc gac cag tcc gga cct cct cac gag ccc 
aag ttc gtt tac caa gca aaa gtt ggg ggt cgc  
 H   G   F   A   A   E   F   K   L   V   D   Q   S   G   P   P   H   E   P   K   
F   V   Y   Q   A   K   V   G   G   R    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 tgg ttc cca gcc gtc tgc gca cac agc aag aag caa ggc aag cag gaa gca gca gat 
gcg gct ctc cgt gtc ttg att ggg gag aac gag  
 W   F   P   A   V   C   A   H   S   K   K   Q   G   K   Q   E   A   A   D   A   
A   L   R   V   L   I   G   E   N   E    
 
 271/91                                   
 |                                        
 aag gca gaa cgc atg ggt ttc aca 
 K   A   E   R   M   G   F   T    
 
 
  
69 
Construct 9 (313bp) 
 1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 gaa tcc atg atg ccc aac aag gtc agg aag att ggc gag ctc gtg aga tac ctg aac 
acc aac cct gtg ggt ggc ctt ttg gag tac gcc  
 E   S   M   M   P   N   K   V   R   K   I   G   E   L   V   R   Y   L   N   T   
N   P   V   G   G   L   L   E   Y   A    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 cgc tcc cat ggc ttt gct gct gaa ttc aag ttg gtc gac cag tcc gga cct cct cac 
gag ccc aag ttc gtt tac caa gca aaa gtt ggg  
 R   S   H   G   F   A   A   E   F   K   L   V   D   Q   S   G   P   P   H   E   
P   K   F   V   Y   Q   A   K   V   G    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 ggt cgc tgg ttc cca gcc gtc tgc gca cac agc aag aag caa ggc aag cag gaa gca 
gca gat gcg gct ctc cgt gtc ttg att ggg gag  
 G   R   W   F   P   A   V   C   A   H   S   K   K   Q   G   K   Q   E   A   A   
D   A   A   L   R   V   L   I   G   E    
 
 271/91                                  301/101                                  
 |                                       |                                        
 aac gag aag gca gaa cgc atg ggt ttc aca gag gta acc cca 
 N   E   K   A   E   R   M   G   F   T   E   V   T   P    
 
 
  
70 
Construct 10 (325bp) 
 1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 gaa tcc atg atg ccc aac aag gtc agg aag att ggc gag ctc gtg aga tac ctg aac 
acc aac cct gtg ggt ggc ctt ttg gag tac gcc  
 E   S   M   M   P   N   K   V   R   K   I   G   E   L   V   R   Y   L   N   T   
N   P   V   G   G   L   L   E   Y   A    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 cgc tcc cat ggc ttt gct gct gaa ttc aag ttg gtc gac cag tcc gga cct cct cac 
gag ccc aag ttc gtt tac caa gca aaa gtt ggg  
 R   S   H   G   F   A   A   E   F   K   L   V   D   Q   S   G   P   P   H   E   
P   K   F   V   Y   Q   A   K   V   G    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 ggt cgc tgg ttc cca gcc gtc tgc gca cac agc aag aag caa ggc aag cag gaa gca 
gca gat gcg gct ctc cgt gtc ttg att ggg gag  
 G   R   W   F   P   A   V   C   A   H   S   K   K   Q   G   K   Q   E   A   A   
D   A   A   L   R   V   L   I   G   E    
 
 271/91                                  301/101                                  
 |                                       |                                        
 aac gag aag gca gaa cgc atg ggt ttc aca gag gta acc cca gtg aca ggg gcc 
 N   E   K   A   E   R   M   G   F   T   E   V   T   P   V   T   G   A    
 
 
  
71 
Construct 11 (331bp) 
 1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 gaa tcc atg atg ccc aac aag gtc agg aag att ggc gag ctc gtg aga tac ctg aac 
acc aac cct gtg ggt ggc ctt ttg gag tac gcc  
 E   S   M   M   P   N   K   V   R   K   I   G   E   L   V   R   Y   L   N   T   
N   P   V   G   G   L   L   E   Y   A    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 cgc tcc cat ggc ttt gct gct gaa ttc aag ttg gtc gac cag tcc gga cct cct cac 
gag ccc aag ttc gtt tac caa gca aaa gtt ggg  
 R   S   H   G   F   A   A   E   F   K   L   V   D   Q   S   G   P   P   H   E   
P   K   F   V   Y   Q   A   K   V   G    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 ggt cgc tgg ttc cca gcc gtc tgc gca cac agc aag aag caa ggc aag cag gaa gca 
gca gat gcg gct ctc cgt gtc ttg att ggg gag  
 G   R   W   F   P   A   V   C   A   H   S   K   K   Q   G   K   Q   E   A   A   
D   A   A   L   R   V   L   I   G   E    
 
 271/91                                  301/101                                  
 |                                       |                                        
 aac gag aag gca gaa cgc atg ggt ttc aca gag gta acc cca gtg aca ggg gcc agt 
ctc 
 N   E   K   A   E   R   M   G   F   T   E   V   T   P   V   T   G   A   S   L    
 
 
 
72 
Construct 12 (338bp) 
 1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 gaa tcc atg atg ccc aac aag gtc agg aag att ggc gag ctc gtg aga tac ctg aac 
acc aac cct gtg ggt ggc ctt ttg gag tac gcc  
 E   S   M   M   P   N   K   V   R   K   I   G   E   L   V   R   Y   L   N   T   
N   P   V   G   G   L   L   E   Y   A    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 cgc tcc cat ggc ttt gct gct gaa ttc aag ttg gtc gac cag tcc gga cct cct cac 
gag ccc aag ttc gtt tac caa gca aaa gtt ggg  
 R   S   H   G   F   A   A   E   F   K   L   V   D   Q   S   G   P   P   H   E   
P   K   F   V   Y   Q   A   K   V   G    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 ggt cgc tgg ttc cca gcc gtc tgc gca cac agc aag aag caa ggc aag cag gaa gca 
gca gat gcg gct ctc cgt gtc ttg att ggg gag  
 G   R   W   F   P   A   V   C   A   H   S   K   K   Q   G   K   Q   E   A   A   
D   A   A   L   R   V   L   I   G   E    
 
 271/91                                  301/101                                 
331/111                                  
 |                                       |                                       
|                                        
 aac gag aag gca gaa cgc atg ggt ttc aca gag gta acc cca gtg aca ggg gcc agt 
ctc aga aga a 
 N   E   K   A   E   R   M   G   F   T   E   V   T   P   V   T   G   A   S   L   
R   R    
 
73 
Construct 13 (298bp) 
 1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 aac ttg gaa tcc atg atg ccc aac aag gtc agg aag att ggc gag ctc gtg aga tac 
ctg aac acc aac cct gtg ggt ggc ctt ttg gag  
 N   L   E   S   M   M   P   N   K   V   R   K   I   G   E   L   V   R   Y   L   
N   T   N   P   V   G   G   L   L   E    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 tac gcc cgc tcc cat ggc ttt gct gct gaa ttc aag ttg gtc gac cag tcc gga cct 
cct cac gag ccc aag ttc gtt tac caa gca aaa  
 Y   A   R   S   H   G   F   A   A   E   F   K   L   V   D   Q   S   G   P   P   
H   E   P   K   F   V   Y   Q   A   K    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 gtt ggg ggt cgc tgg ttc cca gcc gtc tgc gca cac agc aag aag caa ggc aag cag 
gaa gca gca gat gcg gct ctc cgt gtc ttg att  
 V   G   G   R   W   F   P   A   V   C   A   H   S   K   K   Q   G   K   Q   E   
A   A   D   A   A   L   R   V   L   I    
 
 271/91                                   
 |                                        
 ggg gag aac gag aag gca gaa cgc atg 
 G   E   N   E   K   A   E   R   M    
 
 
  
74 
Construct 14 (307bp) 
 1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 aac ttg gaa tcc atg atg ccc aac aag gtc agg aag att ggc gag ctc gtg aga tac 
ctg aac acc aac cct gtg ggt ggc ctt ttg gag  
 N   L   E   S   M   M   P   N   K   V   R   K   I   G   E   L   V   R   Y   L   
N   T   N   P   V   G   G   L   L   E    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 tac gcc cgc tcc cat ggc ttt gct gct gaa ttc aag ttg gtc gac cag tcc gga cct 
cct cac gag ccc aag ttc gtt tac caa gca aaa  
 Y   A   R   S   H   G   F   A   A   E   F   K   L   V   D   Q   S   G   P   P   
H   E   P   K   F   V   Y   Q   A   K    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 gtt ggg ggt cgc tgg ttc cca gcc gtc tgc gca cac agc aag aag caa ggc aag cag 
gaa gca gca gat gcg gct ctc cgt gtc ttg att  
 V   G   G   R   W   F   P   A   V   C   A   H   S   K   K   Q   G   K   Q   E   
A   A   D   A   A   L   R   V   L   I    
 
 271/91                                  301/101                                  
 |                                       |                                        
 ggg gag aac gag aag gca gaa cgc atg ggt ttc aca 
 G   E   N   E   K   A   E   R   M   G   F   T    
 
 
  
75 
Construct 15 (316bp) 
  1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 aac ttg gaa tcc atg atg ccc aac aag gtc agg aag att ggc gag ctc gtg aga tac 
ctg aac acc aac cct gtg ggt ggc ctt ttg gag  
 N   L   E   S   M   M   P   N   K   V   R   K   I   G   E   L   V   R   Y   L   
N   T   N   P   V   G   G   L   L   E    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 tac gcc cgc tcc cat ggc ttt gct gct gaa ttc aag ttg gtc gac cag tcc gga cct 
cct cac gag ccc aag ttc gtt tac caa gca aaa  
 Y   A   R   S   H   G   F   A   A   E   F   K   L   V   D   Q   S   G   P   P   
H   E   P   K   F   V   Y   Q   A   K    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 gtt ggg ggt cgc tgg ttc cca gcc gtc tgc gca cac agc aag aag caa ggc aag cag 
gaa gca gca gat gcg gct ctc cgt gtc ttg att  
 V   G   G   R   W   F   P   A   V   C   A   H   S   K   K   Q   G   K   Q   E   
A   A   D   A   A   L   R   V   L   I    
 
 271/91                                  301/101                                  
 |                                       |                                        
 ggg gag aac gag aag gca gaa cgc atg ggt ttc aca gag gta acc 
 G   E   N   E   K   A   E   R   M   G   F   T   E   V   T    
 
 
  
76 
Construct 16 (325bp) 
1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 aac ttg gaa tcc atg atg ccc aac aag gtc agg aag att ggc gag ctc gtg aga tac 
ctg aac acc aac cct gtg ggt ggc ctt ttg gag  
 N   L   E   S   M   M   P   N   K   V   R   K   I   G   E   L   V   R   Y   L   
N   T   N   P   V   G   G   L   L   E    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 tac gcc cgc tcc cat ggc ttt gct gct gaa ttc aag ttg gtc gac cag tcc gga cct 
cct cac gag ccc aag ttc gtt tac caa gca aaa  
 Y   A   R   S   H   G   F   A   A   E   F   K   L   V   D   Q   S   G   P   P   
H   E   P   K   F   V   Y   Q   A   K    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 gtt ggg ggt cgc tgg ttc cca gcc gtc tgc gca cac agc aag aag caa ggc aag cag 
gaa gca gca gat gcg gct ctc cgt gtc ttg att  
 V   G   G   R   W   F   P   A   V   C   A   H   S   K   K   Q   G   K   Q   E   
A   A   D   A   A   L   R   V   L   I    
 
 271/91                                  301/101                                  
 |                                       |                                        
 ggg gag aac gag aag gca gaa cgc atg ggt ttc aca gag gta acc cca gtg aca 
 G   E   N   E   K   A   E   R   M   G   F   T   E   V   T   P   V   T    
 
 
  
77 
Construct 17 (334) 
 1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 aac ttg gaa tcc atg atg ccc aac aag gtc agg aag att ggc gag ctc gtg aga tac 
ctg aac acc aac cct gtg ggt ggc ctt ttg gag  
 N   L   E   S   M   M   P   N   K   V   R   K   I   G   E   L   V   R   Y   L   
N   T   N   P   V   G   G   L   L   E    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 tac gcc cgc tcc cat ggc ttt gct gct gaa ttc aag ttg gtc gac cag tcc gga cct 
cct cac gag ccc aag ttc gtt tac caa gca aaa  
 Y   A   R   S   H   G   F   A   A   E   F   K   L   V   D   Q   S   G   P   P   
H   E   P   K   F   V   Y   Q   A   K    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 gtt ggg ggt cgc tgg ttc cca gcc gtc tgc gca cac agc aag aag caa ggc aag cag 
gaa gca gca gat gcg gct ctc cgt gtc ttg att  
 V   G   G   R   W   F   P   A   V   C   A   H   S   K   K   Q   G   K   Q   E   
A   A   D   A   A   L   R   V   L   I    
 
 271/91                                  301/101                                 
331/111                                  
 |                                       |                                       
|                                        
 ggg gag aac gag aag gca gaa cgc atg ggt ttc aca gag gta acc cca gtg aca ggg 
gcc agt 
 G   E   N   E   K   A   E   R   M   G   F   T   E   V   T   P   V   T   G   A   
S    
 
78 
Construct 18 (340bp) 
 1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 aac ttg gaa tcc atg atg ccc aac aag gtc agg aag att ggc gag ctc gtg aga tac 
ctg aac acc aac cct gtg ggt ggc ctt ttg gag  
 N   L   E   S   M   M   P   N   K   V   R   K   I   G   E   L   V   R   Y   L   
N   T   N   P   V   G   G   L   L   E    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 tac gcc cgc tcc cat ggc ttt gct gct gaa ttc aag ttg gtc gac cag tcc gga cct 
cct cac gag ccc aag ttc gtt tac caa gca aaa  
 Y   A   R   S   H   G   F   A   A   E   F   K   L   V   D   Q   S   G   P   P   
H   E   P   K   F   V   Y   Q   A   K    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 gtt ggg ggt cgc tgg ttc cca gcc gtc tgc gca cac agc aag aag caa ggc aag cag 
gaa gca gca gat gcg gct ctc cgt gtc ttg att  
 V   G   G   R   W   F   P   A   V   C   A   H   S   K   K   Q   G   K   Q   E   
A   A   D   A   A   L   R   V   L   I    
 
 271/91                                  301/101                                 
331/111                                  
 |                                       |                                       
|                                        
 ggg gag aac gag aag gca gaa cgc atg ggt ttc aca gag gta acc cca gtg aca ggg 
gcc agt ctc aga 
 G   E   N   E   K   A   E   R   M   G   F   T   E   V   T   P   V   T   G   A   
S   L   R    
  
79 
Construct 19 (301bp) 
 1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 ctt gat aac ttg gaa tcc atg atg ccc aac aag gtc agg aag att ggc gag ctc gtg 
aga tac ctg aac acc aac cct gtg ggt ggc ctt  
 L   D   N   L   E   S   M   M   P   N   K   V   R   K   I   G   E   L   V   R   
Y   L   N   T   N   P   V   G   G   L    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 ttg gag tac gcc cgc tcc cat ggc ttt gct gct gaa ttc aag ttg gtc gac cag tcc 
gga cct cct cac gag ccc aag ttc gtt tac caa  
 L   E   Y   A   R   S   H   G   F   A   A   E   F   K   L   V   D   Q   S   G   
P   P   H   E   P   K   F   V   Y   Q    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 gca aaa gtt ggg ggt cgc tgg ttc cca gcc gtc tgc gca cac agc aag aag caa ggc 
aag cag gaa gca gca gat gcg gct ctc cgt gtc  
 A   K   V   G   G   R   W   F   P   A   V   C   A   H   S   K   K   Q   G   K   
Q   E   A   A   D   A   A   L   R   V    
 
 271/91                                   
 |                                        
 ttg att ggg gag aac gag aag gca gaa cgc 
 L   I   G   E   N   E   K   A   E   R    
 
 
  
80 
Construct 20 (313bp) 
 1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 ctt gat aac ttg gaa tcc atg atg ccc aac aag gtc agg aag att ggc gag ctc gtg 
aga tac ctg aac acc aac cct gtg ggt ggc ctt  
 L   D   N   L   E   S   M   M   P   N   K   V   R   K   I   G   E   L   V   R   
Y   L   N   T   N   P   V   G   G   L    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 ttg gag tac gcc cgc tcc cat ggc ttt gct gct gaa ttc aag ttg gtc gac cag tcc 
gga cct cct cac gag ccc aag ttc gtt tac caa  
 L   E   Y   A   R   S   H   G   F   A   A   E   F   K   L   V   D   Q   S   G   
P   P   H   E   P   K   F   V   Y   Q    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 gca aaa gtt ggg ggt cgc tgg ttc cca gcc gtc tgc gca cac agc aag aag caa ggc 
aag cag gaa gca gca gat gcg gct ctc cgt gtc  
 A   K   V   G   G   R   W   F   P   A   V   C   A   H   S   K   K   Q   G   K   
Q   E   A   A   D   A   A   L   R   V    
 
 271/91                                  301/101                                  
 |                                       |                                        
 ttg att ggg gag aac gag aag gca gaa cgc atg ggt ttc aca 
 L   I   G   E   N   E   K   A   E   R   M   G   F   T    
 
 
  
81 
Construct 21 (322bp) 
1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 ctt gat aac ttg gaa tcc atg atg ccc aac aag gtc agg aag att ggc gag ctc gtg 
aga tac ctg aac acc aac cct gtg ggt ggc ctt  
 L   D   N   L   E   S   M   M   P   N   K   V   R   K   I   G   E   L   V   R   
Y   L   N   T   N   P   V   G   G   L    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 ttg gag tac gcc cgc tcc cat ggc ttt gct gct gaa ttc aag ttg gtc gac cag tcc 
gga cct cct cac gag ccc aag ttc gtt tac caa  
 L   E   Y   A   R   S   H   G   F   A   A   E   F   K   L   V   D   Q   S   G   
P   P   H   E   P   K   F   V   Y   Q    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 gca aaa gtt ggg ggt cgc tgg ttc cca gcc gtc tgc gca cac agc aag aag caa ggc 
aag cag gaa gca gca gat gcg gct ctc cgt gtc  
 A   K   V   G   G   R   W   F   P   A   V   C   A   H   S   K   K   Q   G   K   
Q   E   A   A   D   A   A   L   R   V    
 
 271/91                                  301/101                                  
 |                                       |                                        
 ttg att ggg gag aac gag aag gca gaa cgc atg ggt ttc aca gag gta acc 
 L   I   G   E   N   E   K   A   E   R   M   G   F   T   E   V   T    
 
 
  
82 
Construct 22 (330bp) 
1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 ctt gat aac ttg gaa tcc atg atg ccc aac aag gtc agg aag att ggc gag ctc gtg 
aga tac ctg aac acc aac cct gtg ggt ggc ctt  
 L   D   N   L   E   S   M   M   P   N   K   V   R   K   I   G   E   L   V   R   
Y   L   N   T   N   P   V   G   G   L    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 ttg gag tac gcc cgc tcc cat ggc ttt gct gct gaa ttc aag ttg gtc gac cag tcc 
gga cct cct cac gag ccc aag ttc gtt tac caa  
 L   E   Y   A   R   S   H   G   F   A   A   E   F   K   L   V   D   Q   S   G   
P   P   H   E   P   K   F   V   Y   Q    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 gca aaa gtt ggg ggt cgc tgg ttc cca gcc gtc tgc gca cac agc aag aag caa ggc 
aag cag gaa gca gca gat gcg gct ctc cgt gtc  
 A   K   V   G   G   R   W   F   P   A   V   C   A   H   S   K   K   Q   G   K   
Q   E   A   A   D   A   A   L   R   V    
 
 271/91                                  301/101                                  
 |                                       |                                        
 ttg att ggg gag aac gag aag gca gaa cgc atg ggt ttc aca gag gta acc cca gtg 
ac 
 L   I   G   E   N   E   K   A   E   R   M   G   F   T   E   V   T   P   V    
 
 
 
83 
Construct 23 (340bp) 
1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 ctt gat aac ttg gaa tcc atg atg ccc aac aag gtc agg aag att ggc gag ctc gtg 
aga tac ctg aac acc aac cct gtg ggt ggc ctt  
 L   D   N   L   E   S   M   M   P   N   K   V   R   K   I   G   E   L   V   R   
Y   L   N   T   N   P   V   G   G   L    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 ttg gag tac gcc cgc tcc cat ggc ttt gct gct gaa ttc aag ttg gtc gac cag tcc 
gga cct cct cac gag ccc aag ttc gtt tac caa  
 L   E   Y   A   R   S   H   G   F   A   A   E   F   K   L   V   D   Q   S   G   
P   P   H   E   P   K   F   V   Y   Q    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 gca aaa gtt ggg ggt cgc tgg ttc cca gcc gtc tgc gca cac agc aag aag caa ggc 
aag cag gaa gca gca gat gcg gct ctc cgt gtc  
 A   K   V   G   G   R   W   F   P   A   V   C   A   H   S   K   K   Q   G   K   
Q   E   A   A   D   A   A   L   R   V    
 
 271/91                                  301/101                                 
331/111                                  
 |                                       |                                       
|                                        
 ttg att ggg gag aac gag aag gca gaa cgc atg ggt ttc aca gag gta acc cca gtg 
aca ggg gcc agt 
 L   I   G   E   N   E   K   A   E   R   M   G   F   T   E   V   T   P   V   T   
G   A   S    
 
84 
Construct 24 (346bp) 
 1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 ctt gat aac ttg gaa tcc atg atg ccc aac aag gtc agg aag att ggc gag ctc gtg 
aga tac ctg aac acc aac cct gtg ggt ggc ctt  
 L   D   N   L   E   S   M   M   P   N   K   V   R   K   I   G   E   L   V   R   
Y   L   N   T   N   P   V   G   G   L    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 ttg gag tac gcc cgc tcc cat ggc ttt gct gct gaa ttc aag ttg gtc gac cag tcc 
gga cct cct cac gag ccc aag ttc gtt tac caa  
 L   E   Y   A   R   S   H   G   F   A   A   E   F   K   L   V   D   Q   S   G   
P   P   H   E   P   K   F   V   Y   Q    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 gca aaa gtt ggg ggt cgc tgg ttc cca gcc gtc tgc gca cac agc aag aag caa ggc 
aag cag gaa gca gca gat gcg gct ctc cgt gtc  
 A   K   V   G   G   R   W   F   P   A   V   C   A   H   S   K   K   Q   G   K   
Q   E   A   A   D   A   A   L   R   V    
 
 271/91                                  301/101                                 
331/111                                  
 |                                       |                                       
|                                        
 ttg att ggg gag aac gag aag gca gaa cgc atg ggt ttc aca gag gta acc cca gtg 
aca ggg gcc agt ctc aga 
 L   I   G   E   N   E   K   A   E   R   M   G   F   T   E   V   T   P   V   T   
G   A   S   L   R    
  
85 
Construct 25 (307bp) 
 1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 gag tca ctt gat aac ttg gaa tcc atg atg ccc aac aag gtc agg aag att ggc gag 
ctc gtg aga tac ctg aac acc aac cct gtg ggt  
 E   S   L   D   N   L   E   S   M   M   P   N   K   V   R   K   I   G   E   L   
V   R   Y   L   N   T   N   P   V   G    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 ggc ctt ttg gag tac gcc cgc tcc cat ggc ttt gct gct gaa ttc aag ttg gtc gac 
cag tcc gga cct cct cac gag ccc aag ttc gtt  
 G   L   L   E   Y   A   R   S   H   G   F   A   A   E   F   K   L   V   D   Q   
S   G   P   P   H   E   P   K   F   V    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 tac caa gca aaa gtt ggg ggt cgc tgg ttc cca gcc gtc tgc gca cac agc aag aag 
caa ggc aag cag gaa gca gca gat gcg gct ctc  
 Y   Q   A   K   V   G   G   R   W   F   P   A   V   C   A   H   S   K   K   Q   
G   K   Q   E   A   A   D   A   A   L    
 
 271/91                                  301/101                                  
 |                                       |                                        
 cgt gtc ttg att ggg gag aac gag aag gca gaa cgc 
 R   V   L   I   G   E   N   E   K   A   E   R    
 
 
  
86 
Construct 26 (319bp) 
 1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 gag tca ctt gat aac ttg gaa tcc atg atg ccc aac aag gtc agg aag att ggc gag 
ctc gtg aga tac ctg aac acc aac cct gtg ggt  
 E   S   L   D   N   L   E   S   M   M   P   N   K   V   R   K   I   G   E   L   
V   R   Y   L   N   T   N   P   V   G    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 ggc ctt ttg gag tac gcc cgc tcc cat ggc ttt gct gct gaa ttc aag ttg gtc gac 
cag tcc gga cct cct cac gag ccc aag ttc gtt  
 G   L   L   E   Y   A   R   S   H   G   F   A   A   E   F   K   L   V   D   Q   
S   G   P   P   H   E   P   K   F   V    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 tac caa gca aaa gtt ggg ggt cgc tgg ttc cca gcc gtc tgc gca cac agc aag aag 
caa ggc aag cag gaa gca gca gat gcg gct ctc  
 Y   Q   A   K   V   G   G   R   W   F   P   A   V   C   A   H   S   K   K   Q   
G   K   Q   E   A   A   D   A   A   L    
 
 271/91                                  301/101                                  
 |                                       |                                        
 cgt gtc ttg att ggg gag aac gag aag gca gaa cgc atg ggt ttc aca 
 R   V   L   I   G   E   N   E   K   A   E   R   M   G   F   T    
 
 
  
87 
Construct 27 (328bp) 
 1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 gag tca ctt gat aac ttg gaa tcc atg atg ccc aac aag gtc agg aag att ggc gag 
ctc gtg aga tac ctg aac acc aac cct gtg ggt  
 E   S   L   D   N   L   E   S   M   M   P   N   K   V   R   K   I   G   E   L   
V   R   Y   L   N   T   N   P   V   G    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 ggc ctt ttg gag tac gcc cgc tcc cat ggc ttt gct gct gaa ttc aag ttg gtc gac 
cag tcc gga cct cct cac gag ccc aag ttc gtt  
 G   L   L   E   Y   A   R   S   H   G   F   A   A   E   F   K   L   V   D   Q   
S   G   P   P   H   E   P   K   F   V    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 tac caa gca aaa gtt ggg ggt cgc tgg ttc cca gcc gtc tgc gca cac agc aag aag 
caa ggc aag cag gaa gca gca gat gcg gct ctc  
 Y   Q   A   K   V   G   G   R   W   F   P   A   V   C   A   H   S   K   K   Q   
G   K   Q   E   A   A   D   A   A   L    
 
 271/91                                  301/101                                  
 |                                       |                                        
 cgt gtc ttg att ggg gag aac gag aag gca gaa cgc atg ggt ttc aca gag gta acc 
 R   V   L   I   G   E   N   E   K   A   E   R   M   G   F   T   E   V   T    
 
 
  
88 
Construct 28 (329bp) 
1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 gag tca ctt gat aac ttg gaa tcc atg atg ccc aac aag gtc agg aag att ggc gag 
ctc gtg aga tac ctg aac acc aac cct gtg ggt  
 E   S   L   D   N   L   E   S   M   M   P   N   K   V   R   K   I   G   E   L   
V   R   Y   L   N   T   N   P   V   G    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 ggc ctt ttg gag tac gcc cgc tcc cat ggc ttt gct gct gaa ttc aag ttg gtc gac 
cag tcc gga cct cct cac gag ccc aag ttc gtt  
 G   L   L   E   Y   A   R   S   H   G   F   A   A   E   F   K   L   V   D   Q   
S   G   P   P   H   E   P   K   F   V    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 tac caa gca aaa gtt ggg ggt cgc tgg ttc cca gcc gtc tgc gca cac agc aag aag 
caa ggc aag cag gaa gca gca gat gcg gct ctc  
 Y   Q   A   K   V   G   G   R   W   F   P   A   V   C   A   H   S   K   K   Q   
G   K   Q   E   A   A   D   A   A   L    
 
 271/91                                  301/101                                  
 |                                       |                                        
 cgt gtc ttg att ggg gag aac gag aag gca gaa cgc atg ggt ttc aca gag gta acc c 
 R   V   L   I   G   E   N   E   K   A   E   R   M   G   F   T   E   V   T    
 
 
  
89 
Construct 29 (346bp) 
1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 gag tca ctt gat aac ttg gaa tcc atg atg ccc aac aag gtc agg aag att ggc gag 
ctc gtg aga tac ctg aac acc aac cct gtg ggt  
 E   S   L   D   N   L   E   S   M   M   P   N   K   V   R   K   I   G   E   L   
V   R   Y   L   N   T   N   P   V   G    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 ggc ctt ttg gag tac gcc cgc tcc cat ggc ttt gct gct gaa ttc aag ttg gtc gac 
cag tcc gga cct cct cac gag ccc aag ttc gtt  
 G   L   L   E   Y   A   R   S   H   G   F   A   A   E   F   K   L   V   D   Q   
S   G   P   P   H   E   P   K   F   V    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 tac caa gca aaa gtt ggg ggt cgc tgg ttc cca gcc gtc tgc gca cac agc aag aag 
caa ggc aag cag gaa gca gca gat gcg gct ctc  
 Y   Q   A   K   V   G   G   R   W   F   P   A   V   C   A   H   S   K   K   Q   
G   K   Q   E   A   A   D   A   A   L    
 
 271/91                                  301/101                                 
331/111                                  
 |                                       |                                       
|                                        
 cgt gtc ttg att ggg gag aac gag aag gca gaa cgc atg ggt ttc aca gag gta acc 
cca gtg aca ggg gcc agt 
 R   V   L   I   G   E   N   E   K   A   E   R   M   G   F   T   E   V   T   P   
V   T   G   A   S    
 
90 
Construct 30 (352bp) 
1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 gag tca ctt gat aac ttg gaa tcc atg atg ccc aac aag gtc agg aag att ggc gag 
ctc gtg aga tac ctg aac acc aac cct gtg ggt  
 E   S   L   D   N   L   E   S   M   M   P   N   K   V   R   K   I   G   E   L   
V   R   Y   L   N   T   N   P   V   G    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 ggc ctt ttg gag tac gcc cgc tcc cat ggc ttt gct gct gaa ttc aag ttg gtc gac 
cag tcc gga cct cct cac gag ccc aag ttc gtt  
 G   L   L   E   Y   A   R   S   H   G   F   A   A   E   F   K   L   V   D   Q   
S   G   P   P   H   E   P   K   F   V    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 tac caa gca aaa gtt ggg ggt cgc tgg ttc cca gcc gtc tgc gca cac agc aag aag 
caa ggc aag cag gaa gca gca gat gcg gct ctc  
 Y   Q   A   K   V   G   G   R   W   F   P   A   V   C   A   H   S   K   K   Q   
G   K   Q   E   A   A   D   A   A   L    
 
 271/91                                  301/101                                 
331/111                                  
 |                                       |                                       
|                                        
 cgt gtc ttg att ggg gag aac gag aag gca gaa cgc atg ggt ttc aca gag gta acc 
cca gtg aca ggg gcc agt ctc aga 
 R   V   L   I   G   E   N   E   K   A   E   R   M   G   F   T   E   V   T   P   
V   T   G   A   S   L   R    
 
91 
Construct 31 (312bp) 
1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 tca gag tca ctt gat aac ttg gaa tcc atg atg ccc aac aag gtc agg aag att ggc 
gag ctc gtg aga tac ctg aac acc aac cct gtg  
 S   E   S   L   D   N   L   E   S   M   M   P   N   K   V   R   K   I   G   E   
L   V   R   Y   L   N   T   N   P   V    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 ggt ggc ctt ttg gag tac gcc cgc tcc cat ggc ttt gct gct gaa ttc aag ttg gtc 
gac cag tcc gga cct cct cac gag ccc aag ttc  
 G   G   L   L   E   Y   A   R   S   H   G   F   A   A   E   F   K   L   V   D   
Q   S   G   P   P   H   E   P   K   F    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 gtt tac caa gca aaa gtt ggg ggt cgc tgg ttc cca gcc gtc tgc gca cac agc aag 
aag caa ggc aag cag gaa gca gca gat gcg gct  
 V   Y   Q   A   K   V   G   G   R   W   F   P   A   V   C   A   H   S   K   K   
Q   G   K   Q   E   A   A   D   A   A    
 
 271/91                                  301/101                                  
 |                                       |                                        
 ctc cgt gtc ttg att ggg gag aac gag aag gca gaa cgc at 
 L   R   V   L   I   G   E   N   E   K   A   E   R    
 
 
  
92 
Construct 32 (322bp) 
1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 tca gag tca ctt gat aac ttg gaa tcc atg atg ccc aac aag gtc agg aag att ggc 
gag ctc gtg aga tac ctg aac acc aac cct gtg  
 S   E   S   L   D   N   L   E   S   M   M   P   N   K   V   R   K   I   G   E   
L   V   R   Y   L   N   T   N   P   V    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 ggt ggc ctt ttg gag tac gcc cgc tcc cat ggc ttt gct gct gaa ttc aag ttg gtc 
gac cag tcc gga cct cct cac gag ccc aag ttc  
 G   G   L   L   E   Y   A   R   S   H   G   F   A   A   E   F   K   L   V   D   
Q   S   G   P   P   H   E   P   K   F    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 gtt tac caa gca aaa gtt ggg ggt cgc tgg ttc cca gcc gtc tgc gca cac agc aag 
aag caa ggc aag cag gaa gca gca gat gcg gct  
 V   Y   Q   A   K   V   G   G   R   W   F   P   A   V   C   A   H   S   K   K   
Q   G   K   Q   E   A   A   D   A   A    
 
 271/91                                  301/101                                  
 |                                       |                                        
 ctc cgt gtc ttg att ggg gag aac gag aag gca gaa cgc atg ggt ttc aca 
 L   R   V   L   I   G   E   N   E   K   A   E   R   M   G   F   T    
 
 
  
93 
Construct 33 (331bp) 
 1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 tca gag tca ctt gat aac ttg gaa tcc atg atg ccc aac aag gtc agg aag att ggc 
gag ctc gtg aga tac ctg aac acc aac cct gtg  
 S   E   S   L   D   N   L   E   S   M   M   P   N   K   V   R   K   I   G   E   
L   V   R   Y   L   N   T   N   P   V    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 ggt ggc ctt ttg gag tac gcc cgc tcc cat ggc ttt gct gct gaa ttc aag ttg gtc 
gac cag tcc gga cct cct cac gag ccc aag ttc  
 G   G   L   L   E   Y   A   R   S   H   G   F   A   A   E   F   K   L   V   D   
Q   S   G   P   P   H   E   P   K   F    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 gtt tac caa gca aaa gtt ggg ggt cgc tgg ttc cca gcc gtc tgc gca cac agc aag 
aag caa ggc aag cag gaa gca gca gat gcg gct  
 V   Y   Q   A   K   V   G   G   R   W   F   P   A   V   C   A   H   S   K   K   
Q   G   K   Q   E   A   A   D   A   A    
 
 271/91                                  301/101                                  
 |                                       |                                        
 ctc cgt gtc ttg att ggg gag aac gag aag gca gaa cgc atg ggt ttc aca gag gta 
acc 
 L   R   V   L   I   G   E   N   E   K   A   E   R   M   G   F   T   E   V   T    
 
 
  
94 
Construct 34 (332bp) 
 1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 tca gag tca ctt gat aac ttg gaa tcc atg atg ccc aac aag gtc agg aag att ggc 
gag ctc gtg aga tac ctg aac acc aac cct gtg  
 S   E   S   L   D   N   L   E   S   M   M   P   N   K   V   R   K   I   G   E   
L   V   R   Y   L   N   T   N   P   V    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 ggt ggc ctt ttg gag tac gcc cgc tcc cat ggc ttt gct gct gaa ttc aag ttg gtc 
gac cag tcc gga cct cct cac gag ccc aag ttc  
 G   G   L   L   E   Y   A   R   S   H   G   F   A   A   E   F   K   L   V   D   
Q   S   G   P   P   H   E   P   K   F    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 gtt tac caa gca aaa gtt ggg ggt cgc tgg ttc cca gcc gtc tgc gca cac agc aag 
aag caa ggc aag cag gaa gca gca gat gcg gct  
 V   Y   Q   A   K   V   G   G   R   W   F   P   A   V   C   A   H   S   K   K   
Q   G   K   Q   E   A   A   D   A   A    
 
 271/91                                  301/101                                  
 |                                       |                                        
 ctc cgt gtc ttg att ggg gag aac gag aag gca gaa cgc atg ggt ttc aca gag gta 
acc c 
 L   R   V   L   I   G   E   N   E   K   A   E   R   M   G   F   T   E   V   T    
 
 
  
95 
Construct 35 (349bp) 
 1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 tca gag tca ctt gat aac ttg gaa tcc atg atg ccc aac aag gtc agg aag att ggc 
gag ctc gtg aga tac ctg aac acc aac cct gtg  
 S   E   S   L   D   N   L   E   S   M   M   P   N   K   V   R   K   I   G   E   
L   V   R   Y   L   N   T   N   P   V    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 ggt ggc ctt ttg gag tac gcc cgc tcc cat ggc ttt gct gct gaa ttc aag ttg gtc 
gac cag tcc gga cct cct cac gag ccc aag ttc  
 G   G   L   L   E   Y   A   R   S   H   G   F   A   A   E   F   K   L   V   D   
Q   S   G   P   P   H   E   P   K   F    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 gtt tac caa gca aaa gtt ggg ggt cgc tgg ttc cca gcc gtc tgc gca cac agc aag 
aag caa ggc aag cag gaa gca gca gat gcg gct  
 V   Y   Q   A   K   V   G   G   R   W   F   P   A   V   C   A   H   S   K   K   
Q   G   K   Q   E   A   A   D   A   A    
 
 271/91                                  301/101                                 
331/111                                  
 |                                       |                                       
|                                        
 ctc cgt gtc ttg att ggg gag aac gag aag gca gaa cgc atg ggt ttc aca gag gta 
acc cca gtg aca ggg gcc agt 
 L   R   V   L   I   G   E   N   E   K   A   E   R   M   G   F   T   E   V   T   
P   V   T   G   A   S    
 
96 
Construct 36 (355bp) 
 1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 tca gag tca ctt gat aac ttg gaa tcc atg atg ccc aac aag gtc agg aag att ggc 
gag ctc gtg aga tac ctg aac acc aac cct gtg  
 S   E   S   L   D   N   L   E   S   M   M   P   N   K   V   R   K   I   G   E   
L   V   R   Y   L   N   T   N   P   V    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 ggt ggc ctt ttg gag tac gcc cgc tcc cat ggc ttt gct gct gaa ttc aag ttg gtc 
gac cag tcc gga cct cct cac gag ccc aag ttc  
 G   G   L   L   E   Y   A   R   S   H   G   F   A   A   E   F   K   L   V   D   
Q   S   G   P   P   H   E   P   K   F    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 gtt tac caa gca aaa gtt ggg ggt cgc tgg ttc cca gcc gtc tgc gca cac agc aag 
aag caa ggc aag cag gaa gca gca gat gcg gct  
 V   Y   Q   A   K   V   G   G   R   W   F   P   A   V   C   A   H   S   K   K   
Q   G   K   Q   E   A   A   D   A   A    
 
 271/91                                  301/101                                 
331/111                                  
 |                                       |                                       
|                                        
 ctc cgt gtc ttg att ggg gag aac gag aag gca gaa cgc atg ggt ttc aca gag gta 
acc cca gtg aca ggg gcc agt ctc aga 
 L   R   V   L   I   G   E   N   E   K   A   E   R   M   G   F   T   E   V   T   
P   V   T   G   A   S   L   R    
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Construct A (430bp) 
 1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 gag gcg acc aac tcc atg gct tct gat aac cag cct gaa ggt atg atc tca gag tca 
ctt gat aac ttg gaa tcc atg atg ccc aac aag  
 E   A   T   N   S   M   A   S   D   N   Q   P   E   G   M   I   S   E   S   L   
D   N   L   E   S   M   M   P   N   K    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 gtc agg aag att ggc gag ctc gtg aga tac ctg aac acc aac cct gtg ggt ggc ctt 
ttg gag tac gcc cgc tcc cat ggc ttt gct gct  
 V   R   K   I   G   E   L   V   R   Y   L   N   T   N   P   V   G   G   L   L   
E   Y   A   R   S   H   G   F   A   A    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 gaa ttc aag ttg gtc gac cag tcc gga cct cct cac gag ccc aag ttc gtt tac caa 
gca aaa gtt ggg ggt cgc tgg ttc cca gcc gtc  
 E   F   K   L   V   D   Q   S   G   P   P   H   E   P   K   F   V   Y   Q   A   
K   V   G   G   R   W   F   P   A   V    
 
 271/91                                  301/101                                 
331/111                                  
 |                                       |                                       
|                                        
 tgc gca cac agc aag aag caa ggc aag cag gaa gca gca gat gcg gct ctc cgt gtc 
ttg att ggg gag aac gag aag gca gaa cgc atg  
 C   A   H   S   K   K   Q   G   K   Q   E   A   A   D   A   A   L   R   V   L   
I   G   E   N   E   K   A   E   R   M    
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 361/121                                 391/131                                 
421/141                                  
 |                                       |                                       
|                                        
 ggt ttc aca gag gta acc cca gtg aca ggg gcc agt ctc aga aga act atg ctc ctc 
ctc tca agg tcc 
 G   F   T   E   V   T   P   V   T   G   A   S   L   R   R   T   M   L   L   L   
S   R   S    
 
 
Construct B (344bp) 
1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 atg atg ccc aac aag gtc agg aag att ggc gag ctc gtg aga tac ctg aac acc aac 
cct gtg ggt ggc ctt ttg gag tac gcc cgc tcc  
 M   M   P   N   K   V   R   K   I   G   E   L   V   R   Y   L   N   T   N   P   
V   G   G   L   L   E   Y   A   R   S    
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 cat ggc ttt gct gct gaa ttc aag ttg gtc gac cag tcc gga cct cct cac gag ccc 
aag ttc gtt tac caa gca aaa gtt ggg ggt cgc  
 H   G   F   A   A   E   F   K   L   V   D   Q   S   G   P   P   H   E   P   K   
F   V   Y   Q   A   K   V   G   G   R    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 tgg ttc cca gcc gtc tgc gca cac agc aag aag caa ggc aag cag gaa gca gca gat 
gcg gct ctc cgt gtc ttg att ggg gag aac gag  
 W   F   P   A   V   C   A   H   S   K   K   Q   G   K   Q   E   A   A   D   A   
A   L   R   V   L   I   G   E   N   E    
 
99 
 271/91                                  301/101                                 
331/111                                  
 |                                       |                                       
|                                        
 aag gca gaa cgc atg ggt ttc aca gag gta acc cca gtg aca ggg gcc agt ctc aga 
aga act atg ctc ctc c 
 K   A   E   R   M   G   F   T   E   V   T   P   V   T   G   A   S   L   R   R   
T   M   L   L    
 
 
Construct C (351bp) 
 1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 gag gcg acc aac tcc atg gct tct gat aac cag cct gaa ggt atg atc tca gag tca 
ctt gat aac ttg gaa tcc atg atg ccc aac aag  
 E   A   T   N   S   M   A   S   D   N   Q   P   E   G   M   I   S   E   S   L   
D   N   L   E   S   M   M   P   N   K    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 gtc agg aag att ggc gag ctc gtg aga tac ctg aac acc aac cct gtg ggt ggc ctt 
ttg gag tac gcc cgc tcc cat ggc ttt gct gct  
 V   R   K   I   G   E   L   V   R   Y   L   N   T   N   P   V   G   G   L   L   
E   Y   A   R   S   H   G   F   A   A    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 gaa ttc aag ttg gtc gac cag tcc gga cct cct cac gag ccc aag ttc gtt tac caa 
gca aaa gtt ggg ggt cgc tgg ttc cca gcc gtc  
 E   F   K   L   V   D   Q   S   G   P   P   H   E   P   K   F   V   Y   Q   A   
K   V   G   G   R   W   F   P   A   V    
100 
 
 271/91                                  301/101                                 
331/111                                  
 |                                       |                                       
|                                        
 tgc gca cac agc aag aag caa ggc aag cag gaa gca gca gat gcg gct ctc cgt gtc 
ttg att ggg gag aac gag aag gc 
 C   A   H   S   K   K   Q   G   K   Q   E   A   A   D   A   A   L   R   V   L   
I   G   E   N   E   K    
 
 
Construct E (401bp) 
 1/1                                     31/11                                   
61/21                                    
 |                                       |                                       
|                                        
 atg atg ccc aac aag gtc agg aag att ggc gag ctc gtg aga tac ctg aac acc aac 
cct gtg ggt ggc ctt ttg gag tac gcc cgc tcc  
 M   M   P   N   K   V   R   K   I   G   E   L   V   R   Y   L   N   T   N   P   
V   G   G   L   L   E   Y   A   R   S    
 
 91/31                                   121/41                                  
151/51                                   
 |                                       |                                       
|                                        
 cat ggc ttt gct gct gaa ttc aag ttg gtc gac cag tcc gga cct cct cac gag ccc 
aag ttc gtt tac caa gca aaa gtt ggg ggt cgc  
 H   G   F   A   A   E   F   K   L   V   D   Q   S   G   P   P   H   E   P   K   
F   V   Y   Q   A   K   V   G   G   R    
 
 181/61                                  211/71                                  
241/81                                   
 |                                       |                                       
|                                        
 tgg ttc cca gcc gtc tgc gca cac agc aag aag caa ggc aag cag gaa gca gca gat 
gcg gct ctc cgt gtc ttg att ggg gag aac gag  
101 
 W   F   P   A   V   C   A   H   S   K   K   Q   G   K   Q   E   A   A   D   A   
A   L   R   V   L   I   G   E   N   E    
 
 271/91                                  301/101                                 
331/111                                  
 |                                       |                                       
|                                        
 aag gca gaa cgc atg ggt ttc aca gag gta acc cca gtg aca ggg gcc agt ctc aga 
aga act atg ctc ctc ctc tca agg tcc cca gaa  
 K   A   E   R   M   G   F   T   E   V   T   P   V   T   G   A   S   L   R   R   
T   M   L   L   L   S   R   S   P   E    
 
 361/121                                 391/131                                  
 |                                       |                                        
 gca cag cca aag aca ctc cct ctc act ggc agc acc ttc c 
 A   Q   P   K   T   L   P   L   T   G   S   T   F    
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